Prevalencia, severidad y factores de riesgo de síntomas de asma, rinitis y eczema en niños de edad escolar en la provincia Oropeza - Bolivia by Solis Soto, Maria Teresa
Prevalence, severity and risk factors of asthma, rhinitis 
and eczema symptoms in school-aged children from 



































zum Erwerb des Doctor of Philosophy (Ph.D.) 
an der Medizinischen Fakultät der 
Ludwig-Maximilians-Universität zu München 
 
Doctoral Thesis for the awarding of a Doctor of Philosophy (Ph.D.) 






born in (place of birth) 
 
____________________________________
am (Tag an dem die Dissertation abgeschlossen wurde)




Solís Soto, María Teresa
Bolivia
04.29.2013
Supervisors LMU:  
Habilitated Supervisor 
Direct Supervisor 
3rd LMU Supervisor 
























Prof. Dr. Dr. h. c. M. Reiser, FACR, FRCR 
  
































































Thesis Title (cont.) 
 
 
Thesis Title (cont.) 
 
is my own work. I have only used the sources indicated and hav e not made 
unauthorised use of services of a t hird party. Where the work of others has been 
quoted or reproduced, the source is always given.  
 
The submitted thesis or parts thereof have not been pr esented as part of an 
examination degree to any other university.  
 
I further declare that the electronic version of the submitted thesis is congruent with 








   














PhD Program International Health 







TABLE OF CONTENT 
Table of Content ............................................................................................................................................... 2 
i.  List of Figures .......................................................................................................................................... 5 






1.1.1)  Definition and Mechanisms of asthma ................................................................................... 10 
1.1.2)  Asthma Managment ............................................................................................................... 13 
1.1.3)  Epidemiology and Burden of asthma ..................................................................................... 16 
1.2)  Allergic rhinitis ............................................................................................................................... 18 
1.2.1)  Definition and Mechanisms of Allergic Rhinitis .................................................................... 18 
1.2.2)  Allergic rhinitis management ................................................................................................. 20 
1.2.3)  Epidemiology and Burden of Allergic rhinitis ....................................................................... 22 
1.3)  Eczema ............................................................................................................................................ 23 
1.3.1)  Definition and mechanisms of Eczema .................................................................................. 23 
1.3.2)  Management od Eczema ........................................................................................................ 24 
1.3.3)  Epidemiology and Burden of Eczema .................................................................................... 26 
1.4)  The International Study of Asthma and Allergies in Childhood (ISAAC) ..................................... 27 
1.5)  Risk Factors of Asthma Rhinoconjunctivitis and eczema: .............................................................. 29 
1.5.1)  Atopy ...................................................................................................................................... 30 
1.5.2)  Urbanization and modernization ............................................................................................ 31 
1.5.3)  Migration ................................................................................................................................ 32 
1.5.4)  Hygiene .................................................................................................................................. 33 
1.5.5)  Indoor and outdoor pollution .................................................................................................. 34 
1.5.6)  Environmental tobacco smoke ............................................................................................... 36 
1.5.7)  Diet, obesity, and physical activity ........................................................................................ 36 
1.6)  Latin American Situation of asthma, rhinoconjunctivitis and eczema ............................................ 38 
1.6.1)  Epidemiology of asthma in Latin America ............................................................................ 39 





1.6.3)  Epidemiology of eczema in Latin America ............................................................................ 41 
1.7)  Health condition in Bolivia ............................................................................................................. 42 
1.7.1)  Health condition in Chuquisaca ............................................................................................. 45 
1.7.2)  Asthma and allergies in Bolivia and Chuquisaca ................................................................... 46 





3.3)  Study population and field work ..................................................................................................... 50 
3.4)  Study Instruments ........................................................................................................................... 54 
3.5)  Data Handling ................................................................................................................................. 55 
3.6)  Variable definition and statistical analysis ...................................................................................... 56 
3.6.1)  Specific objective 1: Prevalence of asthma, rhinitis and eczema symptoms .......................... 56 
3.6.2)  Specific Objective 2: Association between Environmental factors and asthma, 
rhinoconjunctivitis and eczema symptoms .............................................................................................. 58 
3.6.3)  Specific Objective 3: Association between diet and Asthma symptoms ................................ 61 
3.7)  Ethics .............................................................................................................................................. 65 
4)  Results ..................................................................................................................................................... 66 




4.2)  Association between Environmental factors and asthma, rhinoconjunctivitis and eczema symptoms
  70 
4.3)  Association between diet and Asthma symptoms ........................................................................... 75 
4.3.1)  Food intake and asthma symptoms ........................................................................................ 77 













5.2.1)  Prevalence of Symptoms ........................................................................................................ 83 
5.2.2)  Association between Environmental factors and asthma, rhinoconjunctivitis and eczema 
symptoms 84 




9)  List of Publications .............................................................................................................................. 103 
10)  Appendix .......................................................................................................................................... 104 
10.1)  Information letter for school (in spanish) ...................................................................................... 104 
10.2)  Written questionnaire (in spanish) ................................................................................................ 105 
10.3)  Isaac international video questionnaire answer sheet (in spanish) ................................................ 115 
10.4)  Ehics approval given by the national research ethics committee (in spanish) .............................. 117 
10.5)  Ehics approval given by the National Research Ethics Committee (Official translation) ............. 118 
10.6)  Consent form for parents (in spanish) ........................................................................................... 120 







i. LIST OF FIGURES 
 
Figure 1.1 Bolivian Map………………………………………………………………………………... 42 
Figure 3.1 Map of Oropeza Province. Chuquisaca, Bolivia…………………………………………… 49 
Figure 3.2 Entrance of rural school (La Palma) ………………………………………………………. 52 
Figure 3.3 Implementation of the International Study of Asthma and Allergies in Childhood written 
questionnaire ……………………………………………………………………………………………. 
52 
Figure 3.4 Lunch time in rural school (after questionnaires) ………………………………………… 53 
Figure 3.5 Course picture after survey implementation ……………………………………………….. 53 
 
ii. LIST OF TABLES 
 
Table1.1 Stepped approach for managing atopic eczema in children …………………………………... 26 
Table 1.2 Bolivia: Health Profile ……………………………………………………………………….. 44 
Table 1.3 Sociodemographic indicators of Chuquisaca, Bolivia ………………………..……………… 45 
Table 3.1 Sample size estimated………………………………………………………………………… 51 
Table 3.2 Exposure variables used to explore the association between environmental factors and 
asthma, rhinoconjunctivitis and eczema symptoms ……………………………………………………... 
60 
Table 3.3 Exposure variables used to explore the association between diet and current asthma 
symptoms ………………………………………………………………………………………………... 
63 
Table 4.1 Descriptive data by for place of living (N=2340) …………………………………………… 66 
Table 4.2 Self-reported asthma, rhinitis and eczema symptoms in school aged children in urban and 
rural areas of Chuquisaca Bolivia Prevalence and results of the unadjusted and adjusted logistic 
regression analyses comparing urban and rural areas. ………………………………………………….. 
68 
Table 4.3 Environmental factors and symptoms distribution (N= 2340) ……………………………….. 71 
Table 4.4 Association between environmental factors and asthma, rhinoconjunctivitis and eczema 
symptoms during the past 12 months (unadjusted and adjusted Odds Ratios with 95% Confidence 
Intervals) (N=2340) ……………………………………………………………………………………... 
74 
Table 4.5 Comparison between children included and excluded (N=2340) …………………………… 76 





Table 4.7 Association between the frequency of food groups intake and current asthma symptoms 
during last year (Unadjusted and Adjusted Odds Ratios and 95% Confidence Intervals). Comparison 
group: never or occasionally (N=1655) …………………………………………………………………. 
79 
Table 4.8 Association between different risk factors under study and current asthma symptoms during 






ISAAC: International Study of Asthma and Allergies in Childhood 
GINA: Global Initiative for Asthma  
ARIA: Allergic Rhinitis and its Impact on Asthma 
IgE: Immunoglobulin E 
NICE: The National Institute for Health and Clinical Excellence 
AIRLA: Asthma Insights and Reality in Latin America  
POR: Prevalence odds ratio  







Background: Asthma and allergies are world-wide common chronic diseases among 
children and young people. Little is known about prevalence and environmental and dietary 
risk factors of asthma and allergies among rural and urban school children in Bolivia. The 
aim of this study was to describe the prevalence, severity and risk factors associated with 
asthma, rhinoconjunctivitis, and eczema symptoms in children of school age in Oropeza 
Province – Bolivia 
Methods: Overall, 2584 children (response 91%) attending fifth elementary grade in 
Oropeza province answered the written and the video questionnaire of the International 
Study on Asthma and Allergies in Childhood. Lifetime, 12 months and severity prevalence 
were determined for asthma, rhinoconjunctivitis and eczema symptoms. The associations 
between: environmental and dietary factors and symptoms of asthma, rhinoconjuctivitis and 
eczema symptoms were analysed using logistic regression analysis with adjustment for age, 
sex and place of living. 
Results: Median age of children was 11 years, 52% were female and 26% lived in rural 
areas. The prevalence of asthma symptoms was higher in the written (18%) than in the 
video questionnaire (6%). 22% of children reported symptoms of rhinoconjunctivitis and 
9% eczema symptoms. Overall, rural children reported more frequently symptoms of 
asthma and allergies than urban children. Parental smoking (adjusted OR 1.3; 95%IC 1.0-
1.6), presence of disease vectors at home (fourth quartile vs. first quartile: 1.5; 1.1-2.2) and 
farm animals (1.3; 1.0-1.6) were statistically significant predictors of asthma symptoms 
detected by the written questionnaire. The associations were similar for symptoms of 
rhinoconjunctivitis and eczema. A greater adherence to the Mediterranean Diet (MD) was 
inversely related with asthma symptoms in the video questionnaire (reference category: 1st 
quartile; second quartile 0.6; 0.3-0.9, third quartile 0.7; 0.4-1.2, fourth quartile 0.6; 0.3-1.0) 
Conclusion: Our results suggest that promoting a healthy diet and reducing exposure to 





and certain disease vectors would have a significant positive impact on asthma and allergies 
morbidity in children in this region.  
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Asthma and allergies are world-wide common chronic diseases with high prevalence 
among children and young people and a large variation between and within countries and 
cities1. These pathologies are associated with adverse outcomes at physical, emotional, 
social, and professional level for both, patients and their families, interfering with normal 
activity and quality of life2.  
Asthma and allergies prevalence are increasing in many countries around the world3, and in 
certain developing regions, prevalence has appeared to rise in conjunction with increases in 
urbanization.  Although the reasons for this increase are not clear, studies agree that gene -
environment interaction plays an important role. 
Information on asthma and allergies in Bolivia is scarce. Therefore, this project aimed to 
estimate the prevalence of self-reported asthma, rhinoconjunctivitis and eczema symptoms 
among school-aged children of the ages 9 to 15 of rural and urban areas of Oropeza 
province, Bolivia and explore the relationships between diet and environmental factors with 
the reported symptoms in the study population.  








1.1.1) DEFINITION AND MECHANISMS OF ASTHMA 
 
Global Initiative for Asthma (GINA) defines asthma as a chronic inflammatory disorder of 
the airways in which many cells and cellu lar elements play a role. The chronic 
inflammation is associated wi th airway hyperresponsivene ss that leads to recurrent 
episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night 
or in the early morning. These episodes ar e usually associated with widespread, but 
variable, airflow obstruction within the lung that is often reversible either spontaneously or 
with treatment4. Asthma is a complex, coordinated, multisystem, multicellular, 
inflammatory disorder. The development of asthma requires an interaction between the 
environment and genetic susceptibility5.  
 
Although the clinical spectrum of asthma is highly variable, the presence of airway 
inflammation is a common feature. Airway inflammation is persistent affecting all airways 
in special medium-sized bronchi. This pattern appears to be similar in all clinical forms of 
asthma, whether allergic or nonallergic and at all ages, and is characterized by presence of 
activated mast cells, increased numbers of activated eosinophils, and increased numbers of 
T cell receptor invariant natural killer T cells and T helper 2 lymphocytes (Th2), which 
release mediators that contribute to symptoms6.  
 
In addition to the inflammatory response, there are characteristic structural changes, often 
described as airway remodeling, in the airways of asthma patients. In severe cases of the 
disease these changes result in relatively irreversible narrowing of the airways which is 
considered the final common pathway leading to symptoms and physiological changes in 
asthma7.  





Acute exacerbations: Transient worsening of asthma may occur as a result of exposure to 
risk factors for asthma symptoms, or “triggers,” such as exercise or air pollutants viral 
infections (rhinovirus, respiratory syncytial virus)8 or allergen exposure which increase 
inflammation in the lower airways (acute or chronic inflammation) that may persist for 
several days or weeks. 
Nocturnal asthma: The mechanisms accounting for the worsening of asthma at night are 
not completely understood but may be driven by circadian rhythms of circulating hormones 
such as epinephrine, cortisol, and melatonin and neural mechanisms such as cholinergic 
tone. The occurrence of nocturnal asthma is associated with increased morbidity and 
inadequate asthma control, and has an important negative impact on quality of life9. 
Irreversible airflow limitation : Some patients with severe asthma develop progressive 
airflow limitation. They present longer disease duration, a greater inflammatory process 
airway abnormality suggestive of airway remodeling10. 
Difficult-to-treat asthma: The reasons why some patients develop asthma that is difficult to 
manage and relatively insensitive to the effects of glucocorticosteroids are not well 
understood. Although the pathology appears similar to other forms of asthma, difficult-to-
treat asthma presents an increase in neutrophils, more small airway involvement, and more 
structural changes11. 
Smoking and asthma:  Asthma and active cigarette smoking interact to cause more severe 
symptoms, asthma more difficult to control, accelerated decline in lung function, and 
impaired short-term therapeutic response to corticosteroids. The mechanisms of 
corticosteroid resistance in asthmatic smokers are unexplained, but could be as a result of 
alterations in airway inflammatory cell phenotypes (e.g. increased neutrophils or reduced 
eosinophils), changes in the glucocorticoid receptor-alpha to -beta ratio, and increased 







The interaction between a patient’s genetic makeup and their environment is often 
described in terms of “phenotypes”13. A better characterization of the patients enables 
customization of programs to manage the disease. Although several clinical phenotypes are 
recognized on the basis of cluster analysis of clinical and other features of asthma, we are 
going to mention three phenotypes have been identified in children with asthma Based in 
epidemiological studies 13, 14:  
Transient wheezing: This phenotype is associated with symptoms that are limited to the 
first 3–5 years of life, and are characterized by impaired lung function at birth, maternal 
smoking during pregnancy and exposure to other siblings or children at daycare centers, 
without association of family history of asthma or allergic sensitization. 
Non-atopic wheezing (Non-atopic asthma) : Most of them have a history of viral lower 
respiratory tract infection early in life and are more likely to be wheezing up to 13 years of 
age. 
IgE-mediated wheezing (atopic asthma): This phenotype is associated with high levels of 
atopy, bronchial responsiveness, and impaired lung function. Early allergic sensitization is 
a major risk factor for persistent asthma. 
Late-onset childhood asthma:  This phenotype occurs during or after puberty, affecting 
mainly women and with a low remission rate. It is characterized by a higher prevalence of 













1.1.2) ASTHMA MANAGMENT 
 
Managing the asthma patient involves four key components: diagnosis, pharmacotherapy, 
environmental control and patient education.   
 
Diagnosis 
An early and correct diagnosis is achieved on the basis of medical history, physical 
examination and objective measurements of lung function. The earlier the diagnosis and 
start of treatment, the better the outcome for the patient. 
Medical History: Asthma symptoms may be intermittent and in many cases non-specific. 
This can lead to a misdiagnosis especially among children. However, a clinical diagnosis of 
asthma is often driven by symptoms such as episodic breathlessness, wheezing, cough, and 
chest tightness15 . Some aspects that can help diagnosis are related with episodic symptoms 
after an incidental allergen exposure, seasonal variability of symptoms and a positive 
family history of asthma and atopic disease. Symptoms variability; precipitation by non-
specific irritants, such as smoke, fumes, strong smells, or exercise; worsening at night; and 
responding to appropriate asthma therapy are symptoms that strongly suggest the presence 
of asthma4. Some patients, especially children, have chronic cough (more problematic at 
night) as their principal symptom. Other diagnoses to be considered are cough-induced by 
angiotensin-converting-enzyme (ACE) inhibitors, gastroesophageal reflux, postnasal drip, 
chronic sinusitis, and vocal cord dysfunction16. Physical activity is an important cause of 
asthma symptoms for most asthma patients. Exercise-induced bronchoconstriction typically 
develops within 5-10 minutes after completing exercise and may occur in any climatic 
condition, but it is more common when the patient is breathing dry, cold air17. In this case 
rapid improvement of post-exertion symptoms after inhaled β2-agonist use could guide a 
diagnosis of asthma4 
 
Physical Examination: The physical examination should include the upper respiratory tract 





during symptomatic periods it is possible to find features of hyperinflation and airflow 
limitation (wheezing on auscultation)4. Findings supporting a diagnosis of asthma include 
hyper-expansion of the thorax (especially in children), sounds of wheezing during normal 
(or deep) breathing, signs and symptoms of nasal disease (allergic rhinitis, rhinosinusitis, 
nasal polyps) and in some cases atopic dermatitis/eczema. 
Pulmonary Function Tests: Although diagnosis of asthma is usually based on the presence 
of characteristic symptoms, measurements of lung function provides an assessment of the 
severity of airflow limitation, its reversibility and its variability, and provides confirmation 
of the diagnosis of asthma4. The evaluation of airflow limitation it is possible to perform 
thought spirometry, particularly the measurement of forced expiratory volume in 1 second 
(FEV1) and forced vital capacity (FVC), and peak expiratory flow (PEF) measurement. 
Predicted values of FEV1, FVC, and PEF based on age, sex, and height have been obtained 
from population studies. Among some non-invasive markers of airway inflammation are 
the evaluations of spontaneously produced or hypertonic saline-induced sputum for 
eosinophilic or neutrophilic inflammation18. In addition, levels of exhaled nitric oxide19 and 
carbon monoxide20, although they are not specific for asthma4. 
Once asthma is diagnosed, the patient’s disease severity has to be classified in order to 
determine appropriate therapy. Severity is classified according to: the frequency, duration 
and severity of symptoms; the degree of airflow obstruction and the extent to which the 
disease interferes with daily activities. Asthma severity is a continuum that can change over 
time for any patient4. 
 
Pharmacotherapy 
The goal of asthma treatment is to achieve and maintain clinical control. Asthma control 
focuses on two domains: (1) reducing impairment —the frequency and intensity of 
symptoms and functional limitations currently or recently experienced by a patient; and (2) 
reducing risk —the likelihood of future asthma attacks, progressive decline in lung function 
(or, for children, reduced lung growth), or medication side effects. To achieve and maintain 





that cause worsening symptoms, helping patients learn self-management skills, and 
monitoring over the long term to assess control and adjust therapy accordingly21. 
Medications to treat asthma can be classified as controllers or relievers: 
Controllers: These are medications taken daily on a long-term basis to keep asthma under 
clinical control chiefly through their anti-inflammatory effects. Some of these drugs are: 
inhaled and systemic glucocorticosteroids, longacting inhaled β2-agonists in combination 
with inhaled glucocorticosteroids, sustained-release theophylline, leukotriene modifiers, 
cromones, and anti-IgE. Inhaled glucocorticosteroids are the most effective controller 
medications currently available4.  
Relievers: These are medications used on an as-needed basis that act quickly to reverse 
bronchoconstriction and relieve its symptoms. They include rapid-acting inhaled β2- 




Environmental control measures are an important aspect to reduce symptoms in patients 




As for any chronic disease, an educational plan allows the patient (and family) to 
understand and successfully manage the disease. Patient education should clarify any 
misperceptions about asthma and its treatment. The following aspects have to be 
emphasized: 
• Asthma is a chronic disease; 
• Asthma is physical, not emotional; 
• Medication for asthma is not addictive and does not become ineffective over time; 
• Asthma is best treated with prescription medications; 






1.1.3) EPIDEMIOLOGY AND BURDEN OF ASTHMA 
 
Epidemiology 
Epidemiological studies using validated questionnaires have reported a wide variation in 
asthma prevalence. Studies of both children and adults revealed low prevalence rates (2%–
4%) in Asian countries (especially China and India) and high rates (15%–20%) in the 
United Kingdom, Canada, Australia, New Zealand and other developed countries3, 22.  
Observations of Germany after reunification23, migrating populations24 suggested the role 
of local environmental factors on asthma and gene-environment interactions. This aspects 
are supported by family and twin studies which have shown that although a positive family 
history of asthma predicts an increased risk of asthma, it is neither sufficient nor necessary 
for the development of asthma25.   
 
Burden 
Asthma is one of the most common chronic conditions in the world. It is estimated that 235 
million people worldwide suffer from asthma26. Asthma is under-diagnosed and under-
treated, creating a substantial burden to individuals and families and possibly restricting 
individuals’ activities for a lifetime. It is estimated that asthma accounts for about 250.000 
deaths per year worldwide, most of them preventable with optimal long-term medical care 
and obtaining timely help during the asthma attacks27. 
Annually, approximately 15 million disability-adjusted life years – or approximately 1% of 
all disability-adjusted life years – lost worldwide are due to asthma27. Uncontrolled or 
poorly controlled asthma can: disturb sleep, increase fatigue and decrease energy, produce 
difficulty concentrating, restrict physical activity and exercise, cause absences from work 
and/or school and reduce participation in normal daily activities4. 
 
The economic costs associated with asthma are estimated to rank as one of the highest 





condition. The economic cost of asthma is considerable both in terms of direct medical 
costs (such as hospital admissions and cost of pharmaceuticals) and indirect medical costs 
(such as time lost from work and premature death)28. Both direct and indirect costs 
associated with asthma increase significantly when asthma is not under control. 
 
Among some barriers to reducing the burden of asthma are29: 
- Generic barriers: poverty, poor education, and poor infrastructure. 
- Environmental barriers: indoor and outdoor air pollution, tobacco smoking, and 
occupational exposures. 
- Low public health priority: due the lack of data on morbidity and mortality from 
asthma and the prioritization of other respiratory illnesses such as tuberculosis and 
pneumonia 
- The lack of symptom-based rather than disease-based approaches to the 
management of respiratory diseases. 
- The lack of existence of management guidelines in developing countries, which 
consider the local reality. 
- Inherent barriers in the organization of health care services: geography, education 
and training systems, respiratory specialists. 
- The limited availability and use of medications: omission of basic medications from 
WHO or national essential drug lists, poor supply and distribution infrastructure, 
cost, cultural attitudes towards drug delivery systems.  
- Patient barriers: cultural factors, lack of information, underuse of self-management, 
over-reliance on acute care, use of alternative unproven therapies.  








1.2) ALLERGIC RHINITIS  
 
1.2.1) DEFINITION AND MECHANISMS OF ALLERGIC RHINITIS 
 
Rhinitis has been defined clinically as an inflammation of the lining of the nose and is 
characterized by nasal symptoms including anterior or posterior rhinorrhea, sneezing, nasal 
blockage and/or itching of the nose. These symptoms occur during two or more consecutive 
days for more than one hour on most days. Allergic rhinitis is the most common form of 
non-infectious rhinitis and is associated with an IgE-mediated immune response against 
allergens. It is often associated with ocular symptoms30. 
 
Allergic Rhinitis and its Impact on Asthma (ARIA), proposed a subdivision of rhinitis, 
considering the terms “intermittent” and “persistent”. This classification consider that 
patients with rhinitis more than 4 days a week as persistent rhinitis30.  
Have studies different aspects mechanisms influencing the mechanism of allergic rhinitis. 
Some of them are described below: 
 
Allergic inflammation: The mechanisms of Allergic rhinitis consider a complex 
inflammatory reaction involving cells, mediators, cytokines, chemokines, neuropeptides, as 
well as adhesion molecules and cells co-operate in a complex network provoking the 
specific symptoms and non-specific nasal hyperreactivity.  
 
IgE-dependent mechanisms: Immunoglobulin E (IgE) plays a critical role in the allergic 
inflammatory process in allergic rhinitis. Allergy is generally caused by a sustained 
overproduction of Immunoglobulin IgE in response to common environmental antigens 
such as indoor and outdoor allergens, foods and other allergens31. IgE production is the 
results of complex interactions between T-cells, B-cells, mast cells and basophils, involving 
the presence of the cytokines IL-4, IL-13 and IL-18, as well as a physical interaction 





reported that IgE is produced in the local lymphoid tissues and locally in both the nasal and 
bronchial mucosa33.  
Allergen-specific IgE, synthesized in response to allergens in the environment, becomes 
fixed to FcepsilonRI on the membranes of mast cells and basophils. Mast cell accumulation 
in the airway mucosa is an important pathophysiological event in allergic rhinitis and 
asthma, as inhaled allergens impact the mucosal surfaces of the nose and/or lungs. The 
aggregation of receptor-bound IgE molecules on exposure to specific allergen results in the 
production of mediators (histamine, leukotrienes and others) that produce the allergic 
response34.  The immediate response is characterized by itching, sneezing, rhinorrhoea and 
blockage in the nose. 
 
Non-IgE-dependent mechanisms: It has been studied that allergens may induce 
inflammation independent of IgE, promote directly activate epithelial cells and eventually 
lead to a Th2-immune response, inducing cytokine and chemokine release35. 
 
Remodeling processes: Although epithelial damage is only minimal in the nasal mucosa of 
patients with allergic rhinitis, epithelial cell metaplasia has been observed in the nasal 
biopsies of some patients suffering from perennial rhinitis. Although the nasal and 
bronchial mucosa are exposed to the same noxious environment (and even more so the 
nose), epithelial shedding is more pronounced in the bronchi than in the nose of the same 
patients suffering from asthma and rhinitis36.  
 
Nasal hyperreactivity and non-specific triggers:  Nasal hyperreactivity is an important 
feature of allergic and non-allergic rhinitis. This nasal hyperreactivity is a consequence of 
the overall hyperresponsiveness to non-specific stimuli in daily (tobacco smoke, perfume, 
dust and paint).  This complex process involve different types of nasal tissue (vascular, 
glandular) and also different neuroregulatory systems (adrenergic, cholinergic, peptidergic) 





Links between rhinitis and asthma: The nasal and bronchial mucosa present similarities and 
one of the most important concepts regarding nose-lung interactions is the functional 
complementarity38. The vast majority of patients with asthma have rhinitis, moreover have 
been reported that the presence of allergic rhinitis commonly exacerbates asthma, 
increasing the risk of asthma attacks, emergency visits and hospitalizations for asthma39.  
 
1.2.2) ALLERGIC RHINITIS MANAGEMENT 
 
Next are described the components for and adequate management of Allergic rhinitis: 
 
Diagnosis 
The diagnosis of allergic rhinitis is based in the typical history of allergic symptoms and 
diagnostic tests40.  Clinical history is essential for an accurate diagnosis of allergic rhinitis 
and for the assessment of its severity as well as its response to treatment. Patients with 
allergic rhinitis suffer from sneezing, anterior rhinorrhea, very often from bilateral nasal 
obstruction. This is usually the most troublesome symptom in patients with allergic 
rhinitis40.  
Immediate-hypersensitivity skin tests are widely used to demonstrate an IgE-mediated 
allergic reaction of the skin, and provide useful confirmatory evidence for a diagnosis of 
specific allergy. Skin testing represents one of the primary tools for allergy diagnosis. It is a 
simple, painless and highly efficient method when is carefully performed and correctly 
interpreted including skin tests with high-quality allergen vaccines and a battery that 
includes all the relevant allergens of the patient's context40. 
 
Education 
The education program should consider the following aspects41: 
- The patient or parents of children should be informed about the nature of the 





local area. Education of allergen avoidance and drug therapy (including safety and 
potential side effects) should be provided. 
- Appropriate training in the use of nasal sprays and nasal drops is essential for a 
correct allergic rhinitis management. 
- Patients should be provided with realistic expectations for the results of therapy, 
explaining the need of long-term treatment. 
 
Allergen avoidance 
Although the evidence in controversial for a beneficial effect of allergen avoidance is 
recommended to avoid contact with known allergens and triggers41. 
 
Pharmacotherapy 
Despite allergen and trigger avoidance, many rhinitis sufferers continue to have persistent 
symptoms, the nature of which should determine the selection of medication. For allergic 
rhinitis in children have been described: 
 
First-line treatments41:  
- Antihistamines: These drugs are useful if the main symptoms are rhinorrhea and 
sneezing, or if there are symptoms outside the nose such as conjunctivitis or rash. 
For optimal results, they should be given continuously or prophylactically 
- Nasal steroids: These drugs are useful for nasal congestion and obstruction. 
Intermittent use may be beneficial due to the rapid vasoconstrictor effect of 
corticosteroids. Compliance and efficacy is improved if the child learned how to use 
the nasal spray properly. 
Second-line treatments41: For relief of nasal congestion, is recommended the use of short-
term use of corticosteroid nose drops (e.g. betamethasone or fluticasone) and a topical 
decongestant42.  
Surgical referral for submucosal resection of the inferior turbinate bones may be indicated 






1.2.3) EPIDEMIOLOGY AND BURDEN OF ALLERGIC RHINITIS  
 
Asthma and allergic rhinitis are common health problems that cause major illness and 
disability worldwide40. The International study of asthma and Allergies in Childhood in 
Phase one has reported a prevalence of rhinitis with itchy-watery eyes 
("rhinoconjunctivitis") from 1.4% to 39.7% in 13-14-year-olds, with significant correlation 
between the prevalence of asthma and rhinitis in school children44. Studies reporting 
allergic rhinitis trends showed a global increase in allergic rhinitis in countries where low, 
medium and high prevalence rates were found during ISAAC Phase I, although in some 
countries where the prevalence of allergy and rhinitis was high, a reduction in increase, a 
plateau or a slight reduction have been observed3.  
The prevalence of an IgE sensitization to aeroallergens measured by allergen-specific IgE 
in serum or skin tests is over 40% to 50% in the population of Europe, the USA and 
Australia-New Zealand. Most but not all sensitized subjects suffer from allergic rhinitis and 
or asthma. On the other hand non-allergic rhinitis was reported to account for 30 to 70% of 
patients with chronic perennial rhinitis40. 
 
Allergic rhinitis has been related with a high burden of disease. Has been reported that 
allergic rhinitis involves more than the classical symptoms of sneezing, rhinorrhea and 
nasal obstruction. It is associated with limitation in day-to-day life. Allergic rhinitis has a 
negative impact on sleep, mood, work or school performance, social functioning, 
depression, anxiety and health-related quality of life, especially in patients with moderate 
and severe symptoms. This impact is associated with high direct (health resource costs) and 








1.3) ECZEMA  
 
1.3.1) DEFINITION AND MECHANISMS OF ECZEMA 
 
Eczema is an inflammatory, chronically relapsing and intensely pruritic skin disease. The 
term Eczema has been proposed to describe an aggregation of several skin diseases with 
certain clinical characteristics in common involving a genetically determined skin barrier 
defect. According to the revised nomenclature for allergy, only eczema of patients with 
elevated total serum IgE and specific IgE responses should be called atopic eczema. The 
classification of atopy, is based on IgE sensitization and thus cannot be reached without an 
IgE-antibody determination or skin test. Some studies have reported that non-atopic eczema 
presence during childhood is related with less risk to develop asthma as adolescents than 
for those who had atopic eczema during childhood. However, non-atopic eczema in 
children may develop into atopic eczema45. 
 
Have been described two forms of eczema: 
IgE-mediated sensitization (extrinsic): This form involves around 70–80% of the patients46, 
and is characterized increased levels of Th2 cytokines by memory T cells expressing the 
skin homing receptor, cutaneous lymphocyte-associated antigen (CLA). These include IL-4 
and IL-13, which are known to induce isotype switching to IgE synthesis, as well as IL-5, 
which plays an important role in eosinophil development and survival. These CLA+ T cells 
also produce abnormally low levels of IFN-γ, a Th1 cytokine known to inhibit Th2 cell 
function47. 
 
Non IgE-mediated sens itization (intrinsic): This form involve around 20–30% of the 
patients46, and is associated with less IL-4 and IL-13 production than extrinsic eczema47. 
Both forms have associated eosinophilia. 






Immune responses: Patients with eczema frequently manifests increased dryness and a 
greater irritant skin response than healthy controls. Analyses of biopsies from clinically 
unaffected skin of patients with atopic eczema, as compared with normal non atopic skin, 
showed an increased number of Th2 cells expressing IL-4 and IL-13, but not IFN-γ, 
mRNA48.  
 
Skin barrier dysfunction: Eczema is characterized by dry skin and increased transepidermal 
water loss, in both lesional and nonlesional skin in eczema patients. It lead to an increased 
susceptibility to irritants in eczema, it therefore represent a primary defect of epidermal 
differentiation compounded by the presence of inflammation-induced skin damage47. 
 
Genetics: Eczema is a genetically complex disease with genetic factors playing an 
important role in the development of this disease (20). Have been identified some candidate 
genes involving IgE and Th2 cytokines. A particular focus on chromosome 5q31-33 has 
been reported, as it contains a clustered family of Th2 cytokine genes (i.e., IL-3, IL-4, IL-5, 
IL-13)49. According to hygiene hypothesis, early infections or exposure to microbial-
derived material (such as lipopolysaccharide) early in life prevent the development of Th2-
driven allergic disease. Have been studied that polymorphisms of genes involved in the 
recognition of microbial material may alter the balance between Th1- and Th2-driven 
immune responses and could alter an individual’s susceptibility to development of allergic 
diseases47.  
 
1.3.2) MANAGEMENT OD ECZEMA 
 
The chronic and relapsing nature of eczema causes difficulties to propose and explain long-
term management strategies. Is recommended that healthcare professionals should adopt a 
holistic approach when assessing a child’s atopic eczema considering the severity of the 





psychosocial wellbeing50. Four aspects are considered in management of eczema in 
children: 
Diagnosis 
Eczema is diagnosed clinically. The main characteristics are itchy skin plus three or more 
of the following50:  
- Visible flexural dermatitis involving the skin creases, such as the bends of the 
elbows or behind the knees  
- Personal history of flexural dermatitis  
- Personal history of dry skin in the last 12 months  
- Personal history of asthma or allergic rhinitis (or history of atopic disease in a first-
degree relative of children aged under 4 years)  
- Onset of signs and symptoms under the age of 2 years (this criterion should not be 
used in children aged under 4 years) 
 
Identification and management of trigger factors 
Some of the common triggers are: irritants (soaps and detergents), skin infections, contact 
allergens, food allergens, and inhalant allergens.  
 
Treatment  
The aims of the treatment are to reduce the symptoms, improve quality of life, and decrease 
the degree and frequency of flares. The National Institute for Health and Clinical 
Excellence (NICE) has proposed a stepped approach for managing atopic eczema in 






Table1.1 Stepped approach for managing atopic eczema in children 
Mild atopic eczema Moderate atopic eczema Severe atopic eczema 
Emollients Emollients Emollients 
Mild potency topical 
corticosteroids 
Mild potency topical 
corticosteroids 
Mild potency topical 
corticosteroids 
 Topical calcineurin inhibitors Topical calcineurin inhibitors 
 Bandages Bandages 
  Phototherapy 
  Systemic therapy 
Source: NICE clinical guideline for atopic eczema in children 200750 
 
Children with eczema and their families have to learn how to recognize flares of atopic 
eczema (increased dryness, itching, redness, swelling and general irritability), and how to 
manage flares according to the stepped-care plan. 
 
Education  
Patient and family education is a relevant primary intervention. Education has an important 
role in order to reduce disease severity and improve quality of life51. The education 
program has to emphasize: how much of the treatments to use; how often to apply 
treatments; when and how to step treatment up or down and how to treat infected atopic 
eczema50 
 
1.3.3) EPIDEMIOLOGY AND BURDEN OF ECZEMA 
 
Eczema is a common pediatric dermatosis. The incidence of this disease has increased, like 
asthma, since the 1950s. The International Study of Asthma and Allergies (ISAAC) have 
reported prevalence of eczema symptos ranging from 0.2% in China to 24.6% in Columbia 






Management of atopic eczema in children is potentially complex and costly, often requiring 
a well-planned multidisciplinary approach for optimal care. Some studies have reported 
important cost (direct and indirect) to the patient, their family and their community. Several 
factors may contribute to the higher impact on family impact as: sleep deprivation, time 
taken to care for the child, and interruption to employment. These factors also could affect 
to the community due of lost productivity and sick leave, or cost the individual as loss of 
income. Have been studied other potential reasons for the high impact of eczema on 
families, including parental feelings of guilt, effects of sleep deprivation on parents and 
children, behavioral and socialization skills53, 54.  
 
1.4) THE INTERNATIONAL STUDY OF ASTHMA AND ALLERGIES IN 
CHILDHOOD (ISAAC) 
 
Since 1991, the International Study of Asthma and Allergies in Childhood (ISAAC) has 
reported a large body of new national, regional and global information on the prevalence, 
severity, risk factors, trends and several other aspects related to asthma, rhinoconjunctivitis 
and eczema in childhood. ISAAC, by using standardized methodologies, has permitted 
reasonably reliable comparisons of the prevalence of asthma symptoms between and within 
countries.  
From an early stage, it was conceived as comprising three phases55: 
The aims of ISAAC Phase One were: 
1. To describe the prevalence and severity of asthma, rhinitis and eczema in children living 
in different centres and to make comparisons within and between countries; 
2. To obtain baseline measures for assessment of future trends in the prevalence and 
severity of these diseases; and 
3. To provide a framework for further aetiological research into lifestyle, environmental, 





The aims of ISAAC Phase Two were: 
1. To describe the prevalence of 'objective' markers of asthma and allergies in children 
living in different centres, and to make comparisons within and between centres. 
2. To assess the relation between the prevalence of 'objective' markers of asthma and 
allergies and the prevalence of symptoms of these conditions in children living in different 
centres. 
3. To estimate to what extent the variation in the prevalence and severity of asthma and 
allergies in children between centres can be explained by differences in known or suspected 
risk factors or by differences in disease management. 
4. To explore new aetiological hypotheses regarding the development of asthma and 
allergies in children. 
 
The aims of ISAAC Phase Three were: 
1. To examine time trends in the prevalence of asthma, allergic rhinoconjunctivitis and 
atopic eczema in centres and countries, which participated in ISAAC Phase One. 
2. To describe the prevalence and severity of asthma, allergic rhinoconjunctivitis and atopic 
eczema in centres and countries, which did not participate in Phase One. 
3. To examine hypotheses at an individual level which have been suggested by the findings 
of Phase One, subsequent ecological analyses and recent advances in knowledge. 
 
The results has allowed to estimate the burden of disease associated with these diseases and 
also helps to clarify risk factors and protective factors for the development of these 
pathologies in order to propose appropriate strategies preventing allergic disorders56. 
ISAAC Phase one reported the highest prevalence of asthma and allergic diseases in high-
income populations57 in comparison with some developing countries where the prevalence 
was lower especially in rural areas58. Large variations were reported, even in genetically 
similar groups58, with differences of between 20-fold and 60-fold between centers, 





environmental aspects were explored through ecological analysis and have provided some 
support for hypotheses that economic development59, dietary factors60, climate61, 
infections62 and pollens63 might influence some of this variation. 
ISAAC Phase three, a repetition of Phase one after an interval of at least five years, 
examined variations in time trends of childhood asthma, rhinoconjunctivitis and eczema 
around the world. It was found that in most high prevalence countries, particularly English 
countries, the rise in the prevalence of asthma symptoms has peaked and may even have 
begun to decline. In contrast, many - but not all - countries with low prevalence in Phase 
one had shown increases in prevalence in Phase three3. The causes of these changes remain 
unclear, therefore epidemiological studies are playing a major role in the search for new 
theoretical paradigms, which could explain the reasons for these changes, and could suggest 
developing preventive interventions. 
 
1.5) RISK FACTORS OF ASTHMA RHINOCONJUNCTIVITIS AND ECZEMA: 
 
It is widely accepted that eczema, rhinitis, and asthma are major allergic syndromes in 
childhood and that comorbidity is observed. Some studies have reported allergic rhinitis in 
75% of patients with atopic asthma40. This comorbidity has been attributed to a common 
mechanism of altered immunologic mechanisms favoring a systemic response of type 2 
helper T cell cytokines to environmental allergens 64. A recent publication of the ISAAC 
suggested that factors underling the changing prevalence of symptoms of the three diseases; 
they may be similar around the world even in study centers and countries with diverse 
economic and cultural environments. It suggests that these diseases are mainly determined 
by environmental rather than genetic factors. This is of particular interest, since it is 







Next is described some risk factor which their role has been studied for asthma, 




Atopy is defined as a personal and/or familial tendenc y, usually in childhood or 
adolescence, to become sensitized and produ ce IgE antibodies in response to ordinary 
exposures to allergens, usually proteins. As a consequence, these persons can develop 
typical symptoms of asthma, rhinoconjunctivitis, or eczema45. 
In order to provide more evidence trying to explain the large international variations in 
disease prevalence, ISAAC Phase two include Clinical examinations and skin prick tests to 
explore the role of atopy in these diseases66. In this study atopy was defined as having at 
least 1 positive skin prick test response to any of the allergens tested: house dust mites; cat 
fur; mixed grass pollen; mixed tree pollen; and the outdoor mould genus Alternaria. 
Additional allergens were tested in 18 centers and included cockroach, dog, horse, olive, 
Parietaria officinalis, mixed weeds, Turkish tree mix, mixed molds, and Cladosporium 
species67. 
Although a large variability has been reported worldwide, the results showed at the 
individual level, the association of atopy with asthma, rhinoconjunctivitis and eczema was 
stronger in more affluent centers than in less affluent centers. For current asthma symptoms 
the fraction attributable to atopic sensitization was 40.7% in affluent countries and 20.3% 
in non-affluent countries68. For rhinoconjunctivitis, the population attributable fraction to 
seasonal and perennial allergens was 36 and 25%, respectively in affluent countries and 1.3 
and 12.6%, respectively in non-affluent countries69; and for flexural eczema the population 
attributable fraction for atopy was 27.9% for affluent and 1.2% for non-affluent country 
centers70. 
 
In Latin America, only a small percentage of wheeze was attributable to skin prick test 
reactivity (11% in both Ecuador and Brazil). Although in Latin America the majority of 





Chile reported a high prevalence of atopic asthma71.  In other hand there is evidence that in 
Latin America more severe asthma disease is more likely to be associated with atopy72, 73. 
 
1.5.2) URBANIZATION AND MODERNIZATION 
 
The processes of urbanization and modernization are having profound effects around the 
world. Both processes occur hand in hand and reflect the processes of social and economic 
development, and the adoption of a modern lifestyle74.  
 
Urban populations are growing rapidly in Latin America. In 2010, 79.4% of Latin America 
and Caribbean population resided in urban areas. By 2025, 6 of the 30 largest cities in the 
world are anticipated to be in this region: Bogota, Buenos Aires, Lima, Mexico City, Rio de 
Janeiro, and Sao Paulo. Urban Latin American cities tend to concentrate wealth, creativity, 
innovation, and opportunities on all fronts—from the artistic and cultural, to the technical 
and scientific, to employment and economic. Despite this, the rapid urbanization process in 
Latin America and in Bolivia has strained the capacity of local and national governments to 
provide basic services (e.g. sewage, water, electricity, etc.). Thus, is expected that, in 
coming years, cities will continue to be home to populations in different gradients of 
poverty and vulnerability75. 
Among others, ISAAC showed a higher prevalence of asthma and allergies in industrialized 
countries than in developing countries52, 76, 77. However, in Latin American countries the 
prevalence was shown to be even higher than in industrialized countries, becoming a new 
public health challenge for the region78. Changes in lifestyle, modernization, living 
conditions and dietary habits have been studied as possible explanations for such an 
increase79.  
One aspect frequently shown for industrialized countries is a higher prevalence of asthma 
and allergies in urban compared to rural areas. This association was confirmed for African 
and Asian countries80, 81 but so far only few studies from Latin America exist82, 83. A higher 





underlying the lower prevalence of asthma and allergies in rural areas. However, a high 
prevalence of asthma was shown in inner city environments with high microbial load84, 85. 
Some authors have speculated that these contradictory findings might be related to different 
asthma phenotypes and have hypothesized that rural living protects from allergy but not 





Several studies have examined the association between migration and asthma and allergies 
diseases. Some results showed that birth in a low asthma prevalence country provides some 
protection after migration to a high prevalence country, but that the protection may decline 
with time of residence in the new environment89.  
 
Some studies in Europe90 and Asia91 have examined migration within a country, and have 
provided evidence that birth and residence in a rural environment is protective against 
atopic disease, but this protection may be lost or decreases after migration to a town in 
adulthood. These observations indicate that the protection afforded in environments of low 
asthma risk may not strictly limited to a time window in early life but rather may persist 
through adolescence and adulthood, and be dependent on the continuous presence of 
protective exposures. 
 
Migration of populations from rural to urban areas within a country is likely to be 
associated with changes in many lifestyle and environmental exposures. In developing 
countries in Latin America such as Bolivia, recent rural migrants tend to settle at the 
periphery of a city and bring with them social behaviors and lifestyle choices from their 
rural environment. In the other hand, more established migrants adopt a more urban 
lifestyle, eat a more urban diet, live in concrete houses, and reside in asphalt and concrete 
neighborhoods92. The urban lifestyle may include changes in exposures to pets, infectious 











The hygiene hypothesis, proposed for the first time in 1989 by Strachan, suggests that the 
increase in the prevalence of allergic diseases is linked to a decrease in exposure to germs94. 
This hypothesis appears to be related to the increase in allergic diseases in developed 
countries95. For example, the protective effect of farming observed in a number of studies 
conducted in Europe has been associated with endotoxin exposure in stables and barns81, 96, 
and similar types of microbial exposure could explain the low prevalence of asthma in rural 
Latin America. However in Latin America it was shown that the prevalence of asthma and 
allergies in some low-resourced countries in Latin America with low hygienic standards 
was similar or even higher than in industrialized ones1, 59, 97. 
 
Various studies suggest that exposure to some infectious organisms and bacterial endotoxin 
may provide protect against atopy, whereas other infections appear to promote allergic 
diseases. What does seem to be important is the timing of exposure to infection, the 
properties of the infectious agent itself, and also genetic susceptibility of the host – these 
factors play a significant role in the future development of allergic disease98. 
 
There is evidence that early respiratory viral infections may be important in the 
development of persistent childhood asthma73, 99. Human infection of Toxocara canis, a dog 
helminth parasite, has been implicated as an important risk factor for wheeze in preschool 
children100. Although there is evidence that exposure to intestinal helminth infections may 
enhance bronchial hyper-reactivity and asthma severity73 and that anthelmintic treatment of 
subjects with asthma may reduce both the number of exacerbations and the need for 
medication101, several studies have suggested helminth infections as protective factor for 
allergic diseases and a more attenuated form of asthma102. It is possible that the effects of 





areas of low prevalence may be associated with enhanced bronchial hyper-reactivity and 
asthma symptoms.  
 
Have been studied that family size and the number and order of siblings may affect the risk 
of asthma. The exposure of an infant to a substantial number of infections and many types 
of bacteria stimulates the developing immune system toward non-asthmatic phenotypes. 
Thus the older siblings protect their younger siblings from asthma through a modulating 
effect on the still-maturing immune system94. I this sense some studies have reported that a 
large family size (more than 4 children) is associated with a decreased risk of asthma but 
birth order is not involved103. 
 




Although some epidemiological, human, and animal studies suggest that air pollutants are 
involved in the pathogenesis of asthma, allergic rhinitis, and other allergic disorders, both 
in terms of their development and exacerbation104, the evidence is still inconclusive93. 
Cooking fuel has been reported as another important source of air pollution and is 
associated with significant morbidity and mortality. The use of gas stoves and other 
combustion appliances can lead to higher indoor concentrations of NO2, which is 
potentially harmful to health105. Although several studies have reported that the use of 
domestic gas appliances or exposure to NO2 indoors is associated with respiratory 
symptoms or a diminished lung function in children and adults, the results are 
inconsistent106. 
 
Outdoor air pollution includes gaseous materials such as ozone (O3) and nitrogen dioxide 
(NO2), as well as particulate matter (PM), which is generated by automobile traffic and 
industry. PM and it is considered as the most serious air pollution problem in cities and 
towns, particularly being associated with various adverse health effects. PM is a mixture of 





Diesel exhaust particulate (DEP) accounts for most of the airborne PM (up to 90%) in the 
atmosphere of the world’s largest cities. Acute exposure to diesel exhaust may cause 
irritation of the nose and eyes, headache, lung function disturbances, respiratory changes, 
fatigue and nausea, while chronic exposure is usually associated with chronic cough, 
sputum production and lung function decline. DEP are characterized by both adjuvant 
activity for sensitization against common allergens and enhancing effects on allergic 
symptoms in sensitized patients107.  
 
In Latin American countries, such indoor and outdoor environmental factors vary largely 
between urban and rural areas and by socioeconomic class108, 109. Some epidemiological 
studies in Latin America have reported controversial results in the association between 
asthma and air pollution. The prevalence of asthma symptoms in big Latin American cities 
with well-known high levels of air pollution such as Mexico, Sao Paulo and Santiago were 
much lower (or similar) than places with significantly lesser atmospheric pollution109. 
These results were consistent with the observation of a lower prevalence of asthma in a 
polluted area of East Germany compared to a cleaner area in West Germany23. Current 
evidence, therefore, does not provide strong support for a causal association between 
atmospheric pollution and asthma, although some pollutants may trigger asthma 
exacerbations110. 
 
Currently in Bolivia, air pollution is not perceived as a major problem111. Nevertheless, 
some reports show that air pollution is a particularly serious problem in Bolivia, especially 
in cities on altitudes above 2000 meters, (e.g. La Paz, El Alto and Cochabamba). The most 
significant sources of particles are motor vehicles, industry (particularly bricks production, 
metal foundries and oil refineries), burning of household and agricultural waste. In some 
locations concentrations of particles smaller than 10 microns amount to 106 micrograms 
per cubic meter, which is 2.5 times higher than the average for Latin America and the 
Caribbean, and similar to highly polluted cities such as Santiago (Chile) and Mexico 





uses firewood and other solid fuels for cooking and heating. This is a key cause of 
respiratory infections111. 
1.5.6) ENVIRONMENTAL TOBACCO SMOKE 
 
Environmental tobacco smoke is often thought of as the biggest indoor air pollutant. 
Tobacco smoke contains more than 4,000 chemical substances, many of which are 
carcinogenic, mutagenic, irritating, or toxic113. Combustion byproducts from cigarettes 
have been shown to lead to higher rates of allergy and asthma110. Some studies have shown 
a dose-dependent increase in children’s rates of asthma related to increasing number of 
household smokers, with the strongest effect detected in the youngest children. Maternal 
smoking has been reported to have a stronger effect than other household members’ 
smoking110.  
 
There is also strong evidence to link fetal exposure to maternal active smoking with lower 
birth weight increased risk for sudden infant death syndrome, reduced lung function, and 
increased respiratory tract infections, and asthma. This negative effect has also been 
observed for maternal passive smoking114, and could increase when combined with 
postnatal smoke exposure115. 
The mechanisms by which maternal smoking affect lung function are not fully understood, 
but may include direct toxic effects on the respiratory system and DNA methylation of 
genes116.  
 
1.5.7) DIET, OBESITY, AND PHYSICAL ACTIVITY 
 
Urbanization and the urban lifestyle are likely to be associated with major changes in diet 
and physical activity. These factors have been proposed as risk factors for asthma. Among 
the dietary habits the polyunsaturated fatty acids (PUFAs) have been associated with the 
prevalence of asthma, especially if the diet contains a higher intake of ω-6 (e.g. margarine 





intensify the production of IgE, the formation of arachidonic acid–derived eicosanoids, and 
thus it could promote the development of allergic diseases, diet rich in antioxidants (e.g. 
fruit and vegetables) could prevent from asthma and allergic diseases117.   
 
Findings of ISAAC suggested the Mediterranean diet (MD) as protector from asthma and 
allergies due the lower prevalence of asthma symptoms in the Mediterranean countries118. 
This was confirmed by several studies119-123. Although there are quite a few variants of this 
diet, there are common components like high monounsaturated/saturated fat ratio; high 
consumption of vegetables, fruit, legumes, and grains; moderate consumption of milk and 
low consumption of meat and meat products124. 
The studies carried out so far on the potential link between diet and asthma are conflicting, 
inconsistent, and inconclusive119, 125-127. Very few of these studies were conducted in 
developing countries.  
Although there have been reports of positive associations between body mass index and 
asthma, the mechanism is not clear. Has been suggested that children spending increasing 
periods of time indoors because of changes in leisure habits (e.g. television and video 
games), and because of the risk of physical violence outdoors are likely to be associated 
with increased exposure to indoor allergens and irritants, reduced physical activity, and 
increased obesity93. 
 
Some studies have reported that maternal obesity or underweight, insufficient dietary 
intake, or placental dysfunction could affect fetal nutrition, fetal growth and lung 
development, and subsequently to an increased risk of asthma in childhood128. Have been 
study that Vitamin E, folate, vitamin B12, maternal Mediterranean and Western dietary 
patterns during pregnancy are related to fetal lung growth development, although the 






Studies addressing the link between modifiable environmental factors with asthma and 
allergies are so far scarce in Latin America. It could help to implement prevention 
strategies, which are urgently needed to help reducing the burden of disease around the 
world. 
 
1.6) LATIN AMERICAN SITUATION OF ASTHMA, RHINOCONJUNCTIVITIS AND 
ECZEMA  
 
Latin America comprises 20 countries and 10 dependencies, with around 541 million 
inhabitants130. Race and ethnicity are complex issues in Latin America and Caribe (LAC). 
Most of LAC’s 540 million residents descend from three major racial or ethnic groups: 1) 
Indigenous peoples, of whom there are some 400 distinct groups; 2) Europeans, largely of 
Spanish and Portuguese heritage; and 3) Africans, descendants of slaves brought to the 
region during the colonial era. The term Mestizo generally refers to people of mixed 
European and indigenous lineage, while the term Mulatto refers to people of mixed African 
and European background. Currently, there are numerous racial variations in Latin 
America, making it one of the most – if not the most – diverse regions in the world131. 
 
In the past 30 years, Latin America and the Caribbean region faced marked demographic 
changes, with a substantial decline of mortality and fertility rates, which dropped from 8.72 
to 6.06 per 1000 people and from 4.47 to 2.09, respectively, increase in life expectancy in 
around 9 years (from 65 to 74 years) and the region reported a fast shift in populations from 
rural to urban settings, contributing, as a result, to the formation of mega cities such as 
Mexico City, Sao Paulo and Buenos Aires. On the other hand, information on indigenous 
people indicates that they have higher rates of mortality, morbidity, infant mortality rates 
and maternal mortality ratios than the non-indigenous population. The region has also 
experienced fast and complex epidemiological changes in the past decades, combining 
increasing rates of non-communicable diseases (NCDs) and injuries, while keeping 






ISAAC showed that the worldwide variability of asthma, rhinitis, and atopic eczema is not 
exclusively associated with racial or ethnic factors, moreover other factors such modifiable 
environmental factors could be more important explaining the differences observed in this 
region130. A global analysis of this region showed a high prevalence of asthma and allergic 
symptoms in children living in areas with low socioeconomic development, low hygiene 
and poverty conditions97. 
 
1.6.1) EPIDEMIOLOGY OF ASTHMA IN LATIN AMERICA 
 
The results of ISAAC Phase I reported that the prevalence of asthma symptoms in children 
from South America was as high as that reported from industrialized countries. Overall, the 
prevalence of recent wheeze, exercise-induced bronchospasm, and severe episodes of 
wheezing were 16.9%, 19.3%, and 4.6%, respectively, for children aged 13– 14 years with 
marked differences in asthma symptom prevalence between different countries132. There 
was a trend for asthma prevalence to be lower in centers located at the south latitudes 
(Punta Arenas, Chile and Buenos Aires, Argentina) with higher rates at tropical latitudes 
(Lima, Peru and Recife and Salvador, Brazil); however, these findings were not always 
consistent. In Latin America – in contrast to other countries - no significant difference for 
asthma symptoms was found between boys and girls132. 
After a period of 5–10 years, ISAAC Phase III showed a particular scenario for this region. 
On the one hand, similar or even lower prevalence in asthma symptom was reported in 
centers with high prevalence. It suggests that the prevalence of asthma has reached a 
plateau. On the other hand the increases in low and intermediate prevalence centers suggest 
that asthma prevalence and morbidity might continue to increase in these areas133. 
Asthma in Latin America is associated with significant morbidity. The Asthma Insights and 
Reality in Latin America (AIRLA) survey assessed asthma treatment and control among a 
large sample of asthma patients in seven Latin American countries72. The survey provided 





health services. Overall, only 2.4% of patients met all GINA (the Global Initiative for 
Asthma) criteria for optimal asthma control, and the reasons for this were: poor recognition 
of uncontrolled asthma, under-use of appropriate medications, inadequate patient education 
and lung function monitoring, and low patient expectations.  
 
1.6.2) EPIDEMIOLOGY OF RHINOCONJUNCTIVITIS IN LATIN AMERICA 
 
In ISAAC Phase I, the prevalence of rhinoconjunctivitis symptoms in South American 
centers varied from 10% in Chile to 35% in Paraguay, with three countries in the top 10 list 
of most prevalent worldwide58. Trends study of rhinoconjunctivitis symptoms among South 
American children reported that the symptoms remained high (18.5% for the adolescents 
and 12.7% for the 6-7years old children) and the percentage of change varied widely 
between centers in different countries and also within a same country77.  
No correlation was observed for rhinitis symptoms prevalence with respect to latitude, 
altitude, humid/dry climate or other geographical aspects, suggesting that meteorological 
and geographic factors, individually, would not be able to explain the large variability of 
rhinitis prevalence found by both ISAAC phases in South America78. Comparison of most 
important markers of country development (GNP, infant mortality rate, annual proportion 
of registered deaths under 5 years of age due to infectious diseases, percentage of children 
younger than 1year of age immunized against: poliomyelitis; measles; diphtheria, tetanus, 
and pertussis; and tuberculosis, percentage of population with potable drinkable water 
service, percentage of population with sewage disposal services) and the prevalence of 
rhinitis-related symptoms did not show any significant correlation134. 
The ethnic differences, which might be invoked to explain the variability of rhinitis 






1.6.3) EPIDEMIOLOGY OF ECZEMA IN LATIN AMERICA 
 
ISAAC Phase I showed that atopic eczema is a common health problem for children and 
adolescents throughout the world. In Latin America, was reported a variation in the 
prevalence of symptoms of eczema for 6-7 years old children from 4.8% in Mexico to 
10.9% in Chile and from 4.4% in Mexico to 10.8% in Paraguay for the 13-14 years old. 
Compared with global values, these would be considered in the middle range78.  
As with asthma and rhinitis, the prevalence of symptoms of eczema varies widely, both 
within and between countries inhabited by similar ethnic groups. ISAAC  Phase III showed 
an increase in the prevalence of eczema symptoms. This is particularly evident in Central 
America and the Northern part of South America, where new centers such as La Habana 
(Cuba), San Pedro Sula (Honduras), Managua (Nicaragua), Barranquilla (Colombia), and 
Quito (Ecuador) show prevalence values of more than 15%52. 
 
Some studies reported a lack of association between the mean prevalence of current 
symptoms of eczema and severe eczema in each country and the following: infant mortality 
rate; percentage of children younger than 1 year of age immunized against poliomyelitis, 
measles, diphtheria, tetanus, pertussis, and tuberculosis; percentage of population with 
potable water; percentage of population with sewage disposal services; annual proportion 






1.7) HEALTH CONDITION IN BOLIVIA  
 
Bolivia, located in the center of South America (Figure 1.1), has nine departments, 112 
provinces and 339 municipalities, a land area measuring 1,098,581 km, and a population in 
2012 of more than 10 million inhabitants, as estimated by the National Statistics Institute 
(INE)135. 
 
Figure 1.1 Bolivian Map 
 
Source: Adapted from: http://new.ops.org.bo 
 
Bolivia is characterized by a large number of different cultures. According to the last 2001 
census, roughly 60 per cent of the population self-identified as indigenous belonging to 37 
recognized ethnic groups. Aymaras and Quechuas make up the majority of the Bolivian 
population. More than 37 per cent of the general population continue to live in rural areas 
and 61 per cent of the Spanish-speaking people live in urban areas136.  
Bolivia can be divided into three distinct regions: the highlands (La Paz), the valley region 





climates and vegetation and they attract different types of people. From pre-Columbian 
times till now, Aymara people have dominated the highlands, while the Quechua-speaking 
Incas dominate the valley region. The lowland region was originally sparsely inhabited by a 
number of smaller rainforest tribes, but now has a relatively large population of European 
descent with the low mobility of people from the highlands to the lowlands. This region has 
been growing faster than any other city in Bolivia during the last 50 years111. 
 
Bolivia is the poorest country in the Latin American region with 31% of the population 
living in extreme poverty137. According to socioeconomic indicators, poverty is also more 
severe and extreme among the rural areas92 and indigenous groups136. The main reason for 
the high rural poverty levels is the low level of productivity, which is associated with a lack 
of basic services, such as health services, education, electricity, piped water, and road 
access. One of the reasons that these basic services are lacking in rural Bolivia is that the 
rural population is scattered over vast areas of mountainous or forested terrain. Bolivia’s 
population density is only about 8 persons per square kilometer, which is among the lowest 
in the world. This makes it very expensive to extend basic services to everybody111. It 
keeps the disparities between urban and rural areas. 
Although the GINI coefficient of income distribution declined from 0.59 in 2006 to 0.51 in 
2009, which indicates that there is less inequality in general, urban/rural inequalities persist, 
reflecting the greater vulnerability of the indigenous population138. 
Bolivia is facing the double burden of nutrition: under-nutrition and Overweight. This 
process has been associated with various factors. Progress in improving community infra-
structure and development of sound public health systems has been slow, thwarting efforts 
to reduce under-nutrition; while rapid urbanization and the adoption of Western diets high 
in refined carbohydrates, saturated fats and sugars, combined with a more sedentary 







Non-communicable diseases and a variety of communicable diseases coexist in a complex 
scenario resulting from exposure to both natural disasters and social inequities, which 
makes for major differences in health between population groups. The last Demographic 
Health Surveys (DHS), shown that Bolivia still has the second worst health indicators in 
Latin America. Maternal and infant mortality remain the highest in the region after Haiti 
(Table 1.2). Communicable diseases such as malaria, Chagas disease (American 
trypanosomiasis) and tuberculosis are endemic and, along with HIV-AIDS and emerging 
diseases like dengue, constitute significant social and economic burdens140.  
 




Life expectancy at birth (years) 68 76 
Under five Mortality rate (per 1000 live births) 54 18 
Adult Mortality rate (probably of dying between 15 and 60 years per 
1000 population) 
167 125 
Maternal mortality rate (per 100 000 live births 190 63 
Prevalence of HIV (per 1000 adults aged 15 to 49) 2 5 
Prevalence of tuberculosis (per 100 000 population) 209 36 
Percentage of years of life lost by communicable diseases 55 20 
Percentage of years of life lost by non-communicable diseases 34 59 
Raised blood pressure (aged 25+), 2008 Female 23.5 19.7 
Raised blood pressure (aged 25+), 2008 Male 30.7 26.3 
Obesity (aged 20+), 2008 Female 27.1 29.7 
Obesity (aged 20+), 2008 Male 10.0 23.5 
Tobacco use (aged 15+) Female 18.0 16.0 
Tobacco use (aged 15+) Male 42.0 26.0 







1.7.1) HEALTH CONDITION IN CHUQUISACA 
 
Chuquisaca, located in the center south part of Bolivia, is subdivided into 10 provinces and 
28 municipalities. The estimated population for 2011 was  660.813 distributed in a surface 
area of 51,524 square kilometers136. 
Chuquisaca, also present high percentage of people living in poverty (62%), and 66% of the 
population identify themselves with some ethnic group (Aymara, Quechua, Guaraní, among 
others) (Table 1.3), facing the same health challenges than the country 142, 143. 
 
Table 1.3 Sociodemographic indicators of Chuquisaca, Bolivia 
Indicators Urban Rural 
Poverty (unsatisfied basic needs)  (%)  40,0 89.9 
Adult illiteracy (%) 12,2 37.6 
Infant mortality rate  (per 1000 live births) 53,0 79.8 
Education (years) 9,1 3.2 
People who speak Spanish as a first language (%)  63,4 46.3 
Source : National Institute of Statistics, 2005136 
 
 
Chuquisaca as well as Bolivia is experiencing an epidemiological transition where chronic 
diseases are increasingly becoming more prevalent and straining an already weak health-












1.7.2) ASTHMA AND ALLERGIES IN BOLIVIA AND CHUQUISACA  
 
There is a very little information about asthma and allergies in Bolivia using standardized 
methodologies. The results of one study in Cochabamba (in the valley region) used Peak 
Flow (FPE) measured by Peak Flow Meter (PFM) and Vitalograph Pulmonary Monitor 
(VPM) to detect asthmatics children. Additionally a questionnaire was implemented. The 
study reported a prevalence of 0.91% by objective test and 5.6% by questionnaire. No 
significative difference was found in the history of personal atopy, family history of atopy 
or tobacco at home in this population144. Another study in Cochabamba aimed to identify 
the relationship between toxocariasis, a common zoonotic infection, and asthma in children 
aged 2-13 years old. The results did not show a significant association between asthma and 
toxocariasis, but it found as risk factors family history of asthma, history of previous 
allergies and frequent play with dogs at home145. 
Within the ISAAC study, the prevalence of asthma and allergies in 13-14 years old in 
Bolivia has only been assessed for Santa Cruz, Bolivia’s richest city146. The study has 
shown a high prevalence of current rhinoconjunctivitis (22.4%)77, 78 and eczema symptoms 
(22.5%)130 as compared to other Latin American countries (17.3 and 9.5%, respectively)  
but a moderate prevalence of current asthma symptoms (13.5 Vs. 15.9 % in Latin American 
countries)76, 78. So far, data on the prevalence of asthma and allergies neither exist from 
lower income urban areas nor from rural areas of Bolivia.  
There is a need of studies exploring prevalence and risk factors for asthma and rhinitis with 
standardized methodologies in order to compare and clarify the different factors, which 







2) RATIONALE AND OBJECTIVES 
 
Bolivia - one of the poorest countries in Latin America with a large difference between 
rural and urban areas - offers a unique opportunity to study the prevalence of asthma and 
allergies as well as the environmental and nutritional factors associated with these diseases 
in a multiethnic population. 
 
The aim of this study was therefore to describe the prevalence, severity and risk factors 
associated with asthma, rhinoconjunctivitis, and eczema symptoms in children of school 




1. Explore prevalence and severity of asthma, allergic rhino conjunctivitis, and atopic 
eczema 
2. Explore the association between environmental factors and asthma, 
rhinoconjunctivitis, and eczema symptoms 
3. Explore the association between diet and current asthma symptoms  
 
The results of this cross-sectional study will provide us a baseline for epidemiological 
surveillance of these diseases. The demographic, cultural and epidemiological transition 
observed in Bolivia offer an opportunity to explore the role of risk and protective factors, in 
particular modifiable environmental factors that have been associated with the presence of 
these diseases. The use of standardized methodologies enabled us to compare the results 





clarify which of the assessed factors are leading the wide variability reported for these 
diseases. 
Dissemination of this information will provide evidence of the impact of asthma and 
allergies in the local context, supporting the design and implementation of primary health 









A population-based prevalence study was conducted in the Oropeza Province, located in 
the northwestern part of Chuquisaca, from July 2011 to December 2011. 
 
3.2) SETTING  
 
The estimated population of Oropeza province is around 336.218 inhabitants with 19.7% 
living in the rural area (Figure 3.1). Communities with less than 2000 inhabitants were 
considered rural according to the Bolivian National Statistical Institute 147. 
 










Source: Adapted from: http://www.sucreturistico.gob.bo 
Oropeza`s population lives at altitudes between 2000 and 4000 meters above sea level. Its 





mean annual value around 60%. Rainfall occurs predominantly in summer (average annual 
rainfall of 500 to 1000 cubic millimeters)148.  
 
3.3) STUDY POPULATION AND FIELD WORK 
 
Study population: The study population is children attending the fifth grade at schools 
(public, public with private infrastructure and private) in Oropeza province, Chuquisaca – 
Bolivia. 
In 2010 there 185 schools with fifth grade were registered in the Regional Education 
Service (SEDUCA- Chuquisaca), with a total of 7206 students in the respective grade. 
In contrast to the International Study of Asthma and Allergies in Childhood 
recommendation56, fifth grade was selected due the high drop-out rate in the following 
grades, especially in Bolivian public schools 149, and the difficult to implement the 
International Study of Asthma and Allergies in Childhood  parental questionnaire due the 
low adult literacy level in this region136. Children in this grade are able to understand and 
respond in a proper way, therefore all the study instruments were completed by the children 
themselves. 
 
Sample selection: sampling was conducted in tw o stages: In the first stage 43 schools were 
selected randomly, from which 7 schools (6 urban and 1 rural schools) did not accept to 
participate due to time constraints or because of parental concern. In each sampled school, 
the whole fifth grade student population was studied. From the 36 participating schools, 
2584 children attending the fifth grade were invited to participate, 30 of these schools were 






Exclusion criteria: Schools with less than 20 pupils of this grade were excluded from the 
sampling frame for feasibility reasons, especially the geographical inaccessibility.  Around 
10% (710) of the children attending these schools were excluded from the sampling frame.  
Sample size: The sample size was determined following the International Study of Asthma 
and Allergies in Childhood project recommendations considering 1% of significance level 
and 80% of statistical power56. The calculation for the minimum sample required to 
compare the lowest proportions (severity of wheezing 3% Vs. 5%) are shown in table 3.1. 
 
Table 3.1 Sample size estimated* 
 Significance (%) 
Power (%) 5 1 
80 1251 2241 
90 2016 2855 
*Comparison two proportion (two sides test) in severity of wheezing (0.03 Vs. 0.05) 
Calculated by: www.stat.ubc.ca 
  
Field work: The schools were contacted to agree upon the date of the visit and to organize 
the written and video questionnaire ensuring a place to implement both questionnaires 
properly (see appendix 10.1).  
After the written questionnaire, the International Study of Asthma and Allergies in 
Childhood video questionnaire (AVQ 3.0) was implemented according the International 
Study of Asthma and Allergies in Childhood standard recommendations150. Finally, weight 
and height of the participants were measured according World Health Organization 
recommendations151. The terms: asthma, allergy, rhinitis or eczema were not used in any 
moment. 
The main researcher (MTSS) and three previously trained health professionals submitted 
















Figure 3.3 Implementation of the International Study of Asthma and Allergies in 
























3.4) STUDY INSTRUMENTS  
 
The International Study of Asthma and Allergies in Childhood aimed to evaluate, by a 
standardized methodology, the prevalence and risk factors of asthma and allergic diseases 
in children. For this study, the Spanish version of the International Study of Asthma and 
Allergies in Childhood instruments for 13/14 year were implemented56 (see appendix 10.2). 
 
The ISAAC core questionnaire (asthma, rhinitis and eczema modules) was used152. This 
questionnaire assesses lifetime (ever) and 12 months prevalence (current symptoms) of 
asthma, rhinitis and eczema symptoms. In addition, severity of symptoms is assessed.  
Asthma Module: This module comprises eight questions. These questions were designed as 
a minimum set for inclusion in self‐completed questionnaires used in population surveys of 
respiratory disease in children. The enquiry about symptoms proceeds from the relatively 
mild to the relatively severe153. 
Rhinitis module comprises sex questions and try to distinguish between rhinitis and non‐
rhinitis individuals in the general population, predict which subjects with rhinitis are likely 
to be atopic; and give some indication of the severity of rhinitis among affected 
individuals153. 
Eczema module comprises six questions. These questions were designed as a minimum set 
for inclusion in self‐completed questionnaires used in population surveys of allergic or skin 
disease in children153.  
 
The ISAAC video questionnaire AVQ3.0 designed to assess asthma symptoms 150 was 
implemented according the ISAAC  standard recommendations56. The video questionnaire 
comprised five video sequences of young people from different ethnic origins with various 
asthmatic symptoms. The first three sequences showed various scenes of wheezing 





the final two displayed other asthmatic symptoms (waking at night with coughing, a severe 
attack of asthma with wheezing and breathlessness at rest).  
After each video sequence, students recorded whether their breathing had ever been like 
that shown in the video, and if so, the frequency of such symptoms (past month, past year, 
ever), using a one-page printed answers sheet (See appendix 10.3). 
The video questionnaire took about 10 minutes to administer, and the term “asthma” was 
not mentioned in any time. 
 
Diet and environmental risk factors were assessed with an adapted version of The ISAAC 
environmental questionnaire56. This questionnaire was designed to address overweight, 
diet, exercise, gas cooking, paracetamol, parity, migration, socioeconomic status, traffic, 
allergen and tobacco smoke hypothesis.    
In order to further explore socio-economic and hygiene conditions, questions regarding 
presence of disease vectors at home, number of precarious household characteristics and 
items ownership were added. 
This module comprises 27 multi-choice and short answer questions.  
 
3.5) DATA HANDLING 
 
Double-entry of data and congruence checking was performed using the statistical analysis 
software EpiInfo V. 3.5.3 for Windows to avoid possible mistakes. Data was exported to 









3.6) VARIABLE DEFINITION AND STATISTICAL ANALYSIS 
 
According with the specific objectives proposed, we describe the main analyzes done for 
the PhD research project. In the first analysis we describe the prevalence of asthma, 
rhinoconjuctivitis and eczema symptoms (lifetime, 12 months and severity symptoms 
prevalence); in the second analysis we explore the association between environmental 
factors and current symptoms of asthma, rhinoconjunctivitis and eczema; in the third and 
final analysis we explored the association between diet and current asthma symptoms.  
We present the following variables and statistical analysis performed for each of the 
analysis described above. 
  
3.6.1) SPECIFIC OBJECTIVE 1: PREVALENCE OF ASTHMA, RHINITIS AND ECZEMA 
SYMPTOMS 
 
The following definitions based on the International Study of Asthma and Allergies in 
Childhood protocol were used: 
 Asthma symptoms ever : were defined as self-reported symptoms of wheezing or 
whistling in the chest at any time in the past.  
 Current asthma symptoms: were defined as self-reported symptoms of wheezing or 
whistling in the chest in the last 12 months. 
 Severe asthma: was considered present if children with current asthma symptoms 
reported: 4 or more attacks of wheeze, being woken by wheeze at one or more nights per 
week or wheezing severe enough to limit speech to only one or two words at a time 





 Considering the video questionnaire, wheezing, exercise-induced wheeze and  
dyspnea at rest occurrence were considered by affirmative response to the respective video 
sequences.  
 Rhinitis symptoms ever were defined as self-reported problems of sneezing, runny 
or blocked nose, without having a cold or influenza.  
 Current rhinitis s ymptoms were defined as self-reported problems of sneezing, 
runny or blocked nose, without having a cold or influenza in the last 12 months. 
 Current rhino conjunctivitis symptoms were considered present if participants 
reported current rhinitis symptoms accompanied by itchy watery eyes.  
 Severe allergic rhinitis was defined as rhinoconjunctivitis symptoms interfering 
with daily activities56, 77.  
 Itchy Rash ever was considered if the participant reported an itchy rash which was 
coming and going for at least six months. 
 Current itchy Rash was considered if the participant reported an itchy rash which 
was coming and going for at least six months in the last 12 months . 
 Current symptoms of eczema were defined as presence of an itchy rash in the last 12 
months that affected any of the following places: the folds of the elbows, behind the knees, 
in front of the ankles, under the buttocks, or around the neck, ears or eyes.  
 Severe eczema was considered present if eczema symptoms affected sleep (1 or 
more nights per week) 52, 56.  
 
Absolute and relative frequencies were calculated. The chi-square test was used to assess 
differences between rural and urban areas. Crude and adjusted odds ratios as well as their 
corresponding 95% confidence intervals were calculated using logistic regression analysis. 






3.6.2) SPECIFIC OBJECTIVE 2: ASSOCIATION BETWEEN ENVIRONMENTAL FACTORS AND 
ASTHMA, RHINOCONJUNCTIVITIS AND ECZEMA SYMPTOMS 
 
In the present analysis, the following variables were used as outcome:  
 
 Current asthma symptoms: were defined as self-reported symptoms of wheezing or 
whistling in the chest in the last 12 months.  
 Considering the video questionnaire current asthma symptoms were defined as a 
positive answer to the scene showing “moderate wheeze at rest”. Both the video scene 
selected and the question from the written questionnaire used in for this paper, have shown 
to have the highest degree of agreement evaluating current wheezing150, 154, 155. 
 
 Current rhinitis s ymptoms were defined as self-reported problems of sneezing, 
runny or blocked nose, without having a cold or influenza accompanied by itchy watery 
eyes in the last 12 months. 
 
 Current Eczema Symptoms: were defined as presence of an itchy rash in the last 12 
months that affected any of the following places: the folds of the elbows, behind the knees, 
in front of the ankles, under the buttocks, or around the neck, ears or eyes.  
 
The following definitions were used to assess the exposure variables (Table 3.2): 
 Current exposure to dogs, cats or farm animals (cows, goats, sheep, pigs, hens, 
chickens or turkeys) were defined if children had dog or cat at home, or regular contact (at 
least once a week) with farm animals in the last 12 months.  
 Environmental tobacco smoke exposure was defined present if participants reported 
that their mother, father or guardian smoked at home.  
 Outdoor air pollution was assessed considering the frequency of truck traffic on the 





whole day). Intense truck traffic was considered present when truck traffic was reported 
almost the whole day, in agreement with other studies156-158.  
 The use of wood or coal as cooking fuel was considered a risk factor for the 
outcomes under study.  
 Household conditions precarity was assessed by classifying household by the 
number of precarious household characteristics (none, one and two or more) according to 
the Bolivian National Statistical Institute precarious household characteristic definition159 
(precarious floor: soil; precarious walls: cane, palm or trunk; precarious source of water for 
cooking: river, lake, pump or water tank car; precarious sewage system: surface or septic 
tank). 
 Presence of disease vectors at home (fleas, ticks, kissing bugs, mice, bedbugs and 
flies) was assessed as a proxy of hygiene conditions. For the analysis, the number of types 
of disease vectors was categorized into quartiles (25th percentile = 1 vector; 50th percentile 
2 vectors; 75th percentile ≥ 3 vector).   
 The number of items ownership was explored according to the Bolivian National 
Statistical Institute classification (radio, TV, bicycle, motorbike, car, refrigerator and 
telephone). For the analysis, the number of item ownership was categorized into quartiles 






Table 3.2 Exposure variables used to explore the association between environmental 
factors and asthma, rhinoconjunctivitis and eczema symptoms 
Variable Question Used in the analysis 
Current exposure to 
dog 
In the past 12 months, have you had a 
dog in your home? 
Binary (yes=1, no=0) 
Current  e xposure to 
cat 
In the past 12 months, have you had a cat 
in your home? 
Binary (yes=1, no=0) 
Current  e xposure to 
farm animals 
In the past 12 months, have you had a 
regular contact (at least once a week) 
with farm animals (cows, goats, sheep, 
pigs, hens, chickens or turkeys)? 
Binary (yes=1, no=0) 
Intense truck traffic How often do trucks pass through the 
street where you live? 
Binary: intense truck traffic (almost 
the whole day) and no intense truck 
traffic (never, seldom, frequently 




Does your mother (or guardian) smoke 
cigarettes? Or Does your father (or 
guardian) smoke cigarettes? 
Binary (yes=1, no=0) 
Cooking fuel In your house, what fuel is usually used 
for cooking? 
Binary: wood or coal and other (gas 
or electricity) 
Disease vectors 
presence at home  
 
What vectors are present in your home? 
Binary (yes=1, no=0) for presence of 6 
diseases vectors: fleas, ticks, kissing 
bugs, mice, bedbugs and flies 
Quartiles calculated of the number of 
disease at home 
Precarious household 
conditions  
Binary (yes=1, no=0) for the following 
household conditions:  precarious floor 
(soil), precarious walls (cane, palm or 
trunk), precarious source of water for 
cooking (river, lake, pump or water tank 
car), precarious sewage system (surface 
or septic tank) 
Grouped into three categories: 
None, one and ≥ 2 precarious 
household conditions 
Number of item 
ownership 
What items do you have in your home? 
Binary (yes=1, no=0) for 7 items: radio, 
TV, bicycle, motorbike, car, refrigerator 
and telephone 
Quartiles calculated of the number of 
items ownership  at home 
 
Absolute and relative frequencies were calculated to describe the study population.  
Crude and adjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated 





having asthma, rhinoconjuctivitis and eczema symptoms, given the presence of a potential 
risk factor. The adjusted models included variables which were statistically significant (P 
value ≤ 0.05) in any of the bivariate analysis. In addition, age (three categories: ≤ 10, 11 
and ≥12 years), place of living (two categories: urban and rural), and sex were a-priori 
included in all analyses.  
 
3.6.3) SPECIFIC OBJECTIVE 3: ASSOCIATION BETWEEN DIET AND ASTHMA SYMPTOMS 
 
From a total of 2340 children, 685 children were excluded due incomplete data in the food 
questionnaire, or due to missing data in the outcome variable (in written or video 
questionnaire), giving a final sample of 1655 (70.7% of the participating children) for the 
complete data analysis. 
For the purpose of this study only current asthma symptom was used as an outcome using 
both written and video questionnaire: as previously described, current asthma symptoms 
was defined by the written questionnaire as a positive answer to the question: ‘‘Have you 
had wheezing or whistling in the chest during the last 12 months?’’. In addition current 
asthma symptoms were defined as a positive answer to the first scene of the video 
questionnaire:  “Moderate wheezing at rest” during the last 12 months. 
Both the video scene selected and the question from the written questionnaire used in this 
study have shown to have the highest degree of agreement evaluating current wheezing150, 
154, 155. 
The ISAAC environmental questionnaire  for 13-14 years old children  was used to obtain 
information about nutrition56. The definition of exposure variables is summarized in table 
3.3. The average frequency of consumption for 16 food groups during the past 12 months 
was assessed on a 3 point Likert scale (never or occasionally, 1 or 2 times per week, and 3 
or more times per week). Using this information, the MD score was calculated as described 
in previous studies120. In brief, the consumption of 11 food groups was scored and summed 





 Those considered “pro- Mediterranean” foods (fruit, fish, vegetables, legumes, 
cereals, pasta, rice, and potatoes) were rated according to the frequency of intake (0 points 
= never or occasionally; 1 point = 1 or 2 times/week; 2 points = 3 times/week).  
 Those considered “anti-Mediterranean” foods (meat, milk, and fast food) were rated 
inversely (0 points = 3 times/week; 1 point = 1 or 2 times/week; 2 points = never or 
occasionally) 
The MD score was the sum of the points of each food, which could take a value from 0 to 
22. The higher the score, the greater the adherence to MD.  
 
In addition, the following potential confounders assessed in the environmental 
questionnaire were analyzed:  
 Intense exercise: “How many times a week do you engage in vigorous physical 
activity long enough to make you breathe hard (never or occasionally, once or twice per 
week, three or more times per week)?’’.  
 Presence of sedentary behavior was assessed using two different questions: a) 
“During a normal week, how many hour a day (24hrs) do you watch television?”, and b) 
“During a normal week, how many hour a day (24hrs) do you play videogames?”. These 
two questions were considered different variables and dichotomized by using a cut-off of 3 
hours/day. 
 
BMI was calculated using WHO AnthroPlus software for children between the ages of 5 
and 19 years according to the BMI for age and sex. Finally, BMI was categorized as 
follow160:  
 Normal weight children: children up to +1 standard deviation (SD) of the WHO 
definition. Due a very low number of children with ≤ – 1SD (14 children), the category 
“thin” was included in this category.  
 Overweight children: Children > 1 and ≤+2SDs  





Table 3.3 Exposure variables used to explore the association between diet and current 
asthma symptoms 
Variable Question Used in the analysis 
Food Intake 
In the past 12 months, how often, did 
you eat or drink the following? (meat, 
fish, fruit, vegetables, legumes, cereals, 
pasta, rice, butter, margarine, nuts, 
potatoes, milk, eggs, corn and fast 
food) 
Three categories for each food: 
never or occasionally, once or twice 
per week, three or more times a 
week. 
Mediterranean diet 22 points score based on: 
Pro- Mediterranean foods (fruit, 
fish, vegetables, legumes, cereals, 
pasta, rice, and potatoes) rated 
according to the frequency of intake 
(0 points = never or occasionally; 1 
point = 1 or 2 times/week; 2 points 
= 3 times/week).  
 
Anti-Mediterranean foods (meat, 
milk, and fast food) rated according 
to the frequency of intake (0 points 
= 3 times/week; 1 point = 1 or 2 
times/week; 2 points = never or 
occasionally) 
Intense exercise: How many times a week do you 
engage in vigorous physical activity 
long enough to make you breathe hard? 
Three categories: never or 
occasionally, once or twice per 
week, three or more times per week 
Sedentary behavior During a normal week, how many 
hours a day (24 hours) do you watch 
television? (Less than 1 hour, 1 hour 
but less than 3 hours, 3 hours but less 
than 5 hours and 5 hours or more) 
Binary: ≤ 2 hours per day and ≥ 3 
hours per day 
 During a normal week, how many 
hours a day (24 hours) do you play 
videogames? (Less than 1 hour, 1 hour 
but less than 3 hours, 3 hours but less 
than 5 hours and 5 hours or more) 
Binary: ≤ 2 hours per day and ≥ 3 
hours per day 
Body mass index Measurements of height and weight  Three categories: normal weight, 
overweight and obese children 
 
Absolute and relative frequencies were calculated to describe the study population. 
Selection bias was assessed comparing children with and without complete data using Chi2-






Logistic regression analyses were done to predict current asthma symptoms for the written 
and video questionnaire calculating crude and adjusted odds ratios as well as their 
corresponding 95% confidence intervals.  
In a first approach two models (for WQ and VQ) were built to assess the relation between 
consumption of each food type (1 to 2 times/week or 3 or more times/week compared with 
never or occasionally) and current asthma symptoms, adjusting by variables which were 
statistically significant (P value ≤ 0.05) in the bivariate analysis (age; three categories: ≤ 10, 
11 and ≥12 years), place of living (two categories: urban and rural), and sex which has been 
reported as confounders in the literature121, 161.  
Afterwards in a second approach two models (for WQ and VQ) were built to assess the 
relation between quartiles of MD and current asthma symptoms adjusting for the same 







The study was approved by the National Research Ethics Committee from San Andres 
University at La Paz – Bolivia (see appendix 10.4-10.5); also a permission to apply the 
questionnaire was obtained from the Regional Education Service (SEDUCA- Chuquisaca). 
International ethical research guidelines were considered at all research steps. A written 
informed consent form as well as a letter explaining the importance of the study was sent to 
parents or legal guardians of the children one week before the visit to the school (see 








In the participating schools, response was 91% (2340 children). The median age of 
participating students was 11 years (range from 9 to 15 years) with children from urban 
schools being younger and more likely to attend public schools than children from rural 
schools (Table 4.1). 
 
Table 4.1 Descriptive data by for place of living (N=2340) 
    Urban 
(N=1727) 
Rural 
(N=613) p value* 
    
n % n % 
 




≤ 10 years 
822 48.0 175 28.6 
< 0.01 
11 years 
672 39.3 303 49.4 
≥ 12 years 




1400 81.1 351 57.3 
< 0.01 
Public with private 
Infrastructure 278 16.1 262 42.7 
Private 
49 2.8 - - 






4.1) PREVALENCE OF SYMPTOMS 
 
4.1.1) ASTHMA SYMPTOMS 
 
Based on the written questionnaire, the 12-months prevalence of asthma symptoms was 
16.4% in urban vs. 21.7% in rural areas, while in the video questionnaire asthma symptoms 
were reported by only 7.3% of urban and 3.9% of rural participants (Table 4.2). Adjusting 
for age, sex and type of school these differences were confirmed (urban vs. rural schools: 
written questionnaire OR 0.7; 95% CI 0.5-0.8; video questionnaire 1.7; 1.1-2.7).  
 
4.1.2) RHINITIS SYMPTOMS 
 
The prevalence of rhinitis symptoms was high with a 12-months prevalence of 
rhinoconjunctivitis symptoms of 22% in children from urban and 24% in children from 
rural schools. Only for severe rhinoconjunctivitis symptoms the 12-months prevalence 
differed between urban and rural schools (2.5; 1.0-6.1; table 4.2).  
 
4.1.3) ECZEMA SYMPTOMS 
 
The 12-months prevalence of current itchy rash was higher in urban than in rural schools 
(12% vs. 9%; Table 4.2). The 12-months prevalence of severe eczema was very low (1.6% 
in children from urban schools, 0.5% in children from rural schools). After adjustment, 
only the 12-months prevalence of itchy rash was statically significantly higher in children 





Table 4.2 Self-reported asthma, rhinitis and eczema symptoms in school aged children in 
urban and rural areas of Chuquisaca Bolivia Prevalence and results of the unadjusted and 
adjusted logistic regression analyses comparing urban and rural areas.  
  Urban Rural 
Crude OR Adj. OR 
95%CIb 95% CIb,c 
  n % n % 
ASTHMA 
Written questionnaire (N=2340) 
Asthma symptoms ever  470 27.4 214 34.9 0.7 (0.6-0.9) 0.7 (0.6-0.8) 
Current Asthma symptoms  
(12 months prevalence) 
281 16.4 133 21.7 0.7 (0.6-0.9) 0.7 (0.5-0.8) 
Severe asthmaa 
(12 months prevalence) 
158 9.2 76 12.4 0.7 (0.5 -1.0) 0.7 (0.5-0.9) 
Video Questionnaire (N=2300) 
Wheezing  
(12 months prevalence) 
124 7.3 24 3.9 1.9 (1.2-3.0) 1.7 (1.1-2.7) 
Exercise-induced wheeze 
(12 months prevalence) 
323 19.2 80 13.1 1.6 (1.2-2.1) 1.4 (1.0-1.8) 
Dyspnea at rest 
(12 months prevalence) 
68 4 17 2.8 1.5 (0.9-2.5) 1.2 (0.7-2.2) 
RHINITIS  (N=2327) 
Rhinitis (ever) 715 41.7 255 41.6 1.0 (0.8-1.2) 1.1 (0.9-1.3) 
Rhinitis 
(12 months prevalence) 
490 28.6 175 28.5 1.0 (0.8-1.2) 1.0 (0.8-1.3) 
Rhinoconjunctivitisd  
(12 months prevalence)  
369 21.5 147 24.0 0.9 (0.7-1.1) 0.9 (0.7-1.1) 
Severe Rhinoconjunctivitise 
(12 months prevalence) 





Table 4.2 (continued) 
  Urban Rural 
Crude OR Adj. OR 
95%CIb 95% CIb,c 
  n % n % 
ECZEMA (N=2303) 
Itchy rash (ever) 339 20 123 20.1 1.0 (0.8-1.3) 1.0 (0.8-1.3) 
Itchy rash 
(12 months prevalence) 
203 12.0 56 9.2 1.4 (1.0-1.8) 1.4 (1.0-2.0) 
Eczemaf 
(12 months prevalence) 
161 9.5 52 8.5 1.1 (0.8-1.6) 1.2 (0.8-1.7) 
Severe Eczemag 
(12 months prevalence) 
27 1.6 3 0.5 3.3 (1.0-10.9) 2.9 (0.8-9.8) 
a ≥ 4 attacks of wheeze or woken by wheeze on one or more nights per week or wheezing severe enough to limit speech to only one or 
two words at a time, between breaths.  
b Reference category: rural 
c Adjusted by age, sex and type of school 
d Presence of sneezing or a runny or blocked nose, accompanied by itchy watery eyes without a cold or the flu. 
e Rhinoconjunctivitis symptoms interfering with daily activities (a lot). 
f Presence of an itchy rash at any time in the past 12 months affecting the following places: the folds of the elbows; behind the knees; in 
front of the ankles; under the buttocks; or around the neck, ears, or eyes) 






4.2) ASSOCIATION BETWEEN ENVIRONMENTAL FACTORS AND ASTHMA, 
RHINOCONJUNCTIVITIS AND ECZEMA SYMPTOMS 
 
37% of children reported that at least one of their parents smoked at home. Wood or coal 
was used at cooking fuel in 19% of the homes. About one third of the study population 
reported intense truck traffic on the street where they lived (29%).  
The hygiene condition results showed that exposure to dogs (86%) and cats (59%) was 
common. Regular contact to farm animals was reported by more than one third of the study 
population (36%). More than one precarious household condition was reported by 8% of 
children.  
The prevalence of current asthma symptoms based on the written questionnaire was 18%, 
6% reported asthma symptoms according to the video questionnaire. Prevalence of 













Table 4.3 Environmental factors and symptoms distribution (N= 2340) 
Variables  % (n) 
Place of living Rural  26.2 (613) 
Current exposure to dog  86.2 (2003) 
Current  exposure to cat  59.2 (1375) 
Current  exposure to farm animals  36.1 (837) 
Intense truck traffic1  28.6 (655) 
Environmental tobacco smoke exposure  37.1 (868) 
Cooking fuel Wood or coal 18.5 (431) 
Disease vectors presence at home 2  
(Median 2; Range 0 to 6) 
None 8.4 (197) 
 1 Vector 39.3 (920) 
 2 Vectors 23.9 (559) 
 3  Vectors 16.5 (385) 
 ≥ 4  Vectors 12.0 (279) 
Precarious household conditions 3 None 70.6 (1615) 
 1 21.2 (484) 
 ≥ 2 8.2 (188) 
Number of item ownership4 
(Median 4; Range 0 to 7) 
None 0.6 (13) 
 1 item 6.4 (149) 
 2  items 7.4 (173) 
 3  items 16.4 (383) 
 4  items 22.3 (522) 
 5  items 22.3 (521) 





Table 4.3 (continued) 
 
1Intense truck traffic: Almost the whole day 
2Disease vectors: fleas, ticks, kissing bugs, mice, bedbugs, flies 
3 Precarious floor: soil; Precarious walls: cane, palm or trunk; Precarious source of water for cooking: river, lake, pump or water tank car; 
Precarious sewage system: to the surface or to a septic tank 
4 Item ownership: Radio, TV, bicycle, motorbike, car, refrigerator, telephone 
5 Positive answer to the question: ‘‘Have you had wheezing or whistling in the chest during the last 12 months?’’in the written 
questionnaire. 
6 Positive answer to the first scene of the video questionnaire: Moderate wheezing at rest 
7 Presence of sneezing or a runny or blocked nose, accompanied by itchy watery eyes without a cold or the flu. 
8 Presence of an itchy rash at any time in the past 12 months affecting the following places: the folds of the elbows; behind the knees; in 
front of the ankles; under the buttocks; or around the neck, ears, or eyes). 
 
 
The unadjusted and adjusted models showed that current exposure to animals (dog, cat or 
farm animals), intense truck traffic, exposure to tobacco smoke, wood or coal as cooking 
fuel, two or more precarious household conditions were associated with an increase in 
asthma symptoms either in the written or video questionnaire. Presence of disease vectors 
at home showed a dose-response effect, with the highest quartile having the highest risk for 
asthma symptoms (Table 4.4). The associations were similar for all three conditions 
(asthma, rhinoconjunctivitis and eczema symptoms), however, not reaching the level of 
statistical significance for all items. 
Variables  % (n) 
Symptoms 
Current asthma symptoms WQ5  17.8 (414) 
Current asthma symptoms VQ6  6.4 (148) 
Current rhinoconjunctivitis symptoms7  22.2 (516) 





Table 4.4 Association between environmental factors and asthma, rhinoconjunctivitis and eczema symptoms during the past 12 
months (unadjusted and adjusted Odds Ratios with 95% Confidence Intervals) (N=2340) 
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Table 4.4 (continued) 
 
    
 













































Number of item ownership10 
Quartile 1 
 
1 - 1 - 1 - 1 - 




































 1 Positive answer to the question: ‘‘Have you had wheezing or whistling in the chest during the last 12 months?’ ’in the written questionnaire. 
2 Positive answers to the first scene of the video questionnaire: Moderate wheezing at rest 
3 Presence of sneezing or a runny or blocked nose, accompanied by itchy watery eyes without a cold or the flu. 
4 Presence of an itchy rash at any time in the past 12 months affecting the following places: the folds of the elbows; behind the knees; in front of the ankles; under the buttocks; or around the neck, ears, 
or eyes 
5Adjusted by sex, age and place of living  
6 Comparison group: no contact / exposure 
7Intense truck traffic: Almost the whole day 
8Disease vectors: fleas, ticks, kissing bugs, mice, bedbugs, flies 
9 Precarious floor: soil; Precarious walls: cane, palm or trunk; Precarious source of water for cooking: river, lake, pump or water tank car; Precarious sewage system: to the surface or to a septic tank 





4.3) ASSOCIATION BETWEEN DIET AND ASTHMA SYMPTOMS  
Comparing the 685 children with missing data to those with complete data showed that 
they were statistically significantly older. In addition, they tended to watch less TV 
(pChi
2=0.08). No other major differences could be found between the two groups (Table 
4.5).  
 Table 4.5 Comparison between children included and excluded (N=2340)  
1 All the food questions are completed; 2 One or more food questions are missing; 
3 Chi square Test; 4 Positive answer to the question: 
‘‘Have you had wheezing or whistling in the chest during the last 12 months?’’ in the written questionnaire. 
5Positive answer to the first scene of the video questionnaire: Moderate wheezing at rest 
 







Female 862 (52.1) 355 (52.0) 
0.94 




≤ 10 years 737 (44.7) 260 (38.5) 
0.02 11 years 669 (40.6) 306 (45.3) 
≥ 12 years 243 (14.7) 110 (16.3) 
Place of living Rural  420 (25.4) 193 (28.3) 
0.16 
Urban 1235 (74.6) 492 (71.8) 
Asthma symptoms (12 m onths 
prevalence)  
Written Questionnaire4 281 (17.0) 133 (19.7) 0.12 
Video Questionnaire5 105 (6.3) 43 (6.7) 0.78 
Body mass index  Normal weight 1071 (65.0) 452 (67.2) 
0.39 Overweight 451 (27.4) 180 (26.7) 
Obesity 125 (7.6) 41 (6.1) 
Intense exercise  
  
  
Never/ Occasionally 278 (16.9) 129 (19.6) 
0.28 1-2 times per week 845 (51.4) 321 (48.7) 
≥ 3 times per week 520 (31.6) 209 (31.7) 
Time watching television  
  
≤ 2 hours per week 1024 (63.1) 438 (67.1) 
0.08 
>3 hours per week 598 (36.9) 215 (32.9) 
Time playing video games  
  
≤ 2 hours per day 1309 (87.7) 514 (86.0) 
0.27 
>3 hours per day 183 (12.3) 84 (14.0) 





The median age of children with complete data was 11 years (range 9 to 15 years), and 52% 
were female. The prevalence of current asthma symptoms was 17% in the WQ and 6% in 
the VQ. Around 35% of the children were overweight or obese. The study population 
showed low to medium adherence to the MD, with a median score of 13 points (range 3 to 
22 points) (Table 4.5). The consumption of fruits, vegetables, cereals, rice, and potatoes 
three or more times a week was higher (>50%) than the other food types (Table 4.6). 
 
Table 4.6 Intake frequencies of different foods (N=1655) 
Food Never or occasionally Once or twice a week Three or more times a week 
 n % n % n % 
Meat  189 11.4 868 52.4 598 36.1 
Fish 804 48.6 679 41.0 172 10.4 
Fruit  111 6.7 506 30.6 1038 62.7 
Vegetables 156 9.4 519 31.4 980 59.2 
Pulses 555 33.5 743 44.9 357 21.6 
Cereal 205 12.4 458 27.7 992 59.9 
Pasta 251 15.2 720 43.5 684 41.3 
Rice 114 6.9 609 36.8 932 56.3 
Butter  692 41.8 670 41.2 265 16.3 
Margarine 921 58.1 458 28.9 207 13.1 
Nuts 523 32.2 742 45.7 357 22.0 
Potatoes 99 6.0 384 23.2 1172 70.8 
Milk  209 12.6 770 46.5 676 40.8 
Eggs 186 11.4 874 53.7 567 34.8 
Corn 493 30.8 742 46.4 364 22.8 








4.3.1) FOOD INTAKE AND ASTHMA SYMPTOMS 
 
Overall, no statistically significant association was shown between food consumption and 
asthma symptoms. For both asthma definitions there was a tendency that corn and fast food 
consumption increased the risk of asthma symptoms while fruit, vegetables, cereal, rice, 
butter, milk consumption decreased the risk of asthma symptoms (Table 4.7).  
While margarine and nuts seemed to be a risk factor for asthma based on the WQ there was 
a tendency for a protective effect of both in the VQ. Finally, pasta consumption was not 
statistically significantly inversely related with asthma symptoms only in the VQ. Adjusted 





Table 4.7 Association between the frequency of food groups intake and current asthma symptoms during last year (Unadjusted and 
Adjusted Odds Ratios and 95% Confidence Intervals). Comparison group: never or occasionally (N=1655). 
 
 Written questionnaire Video questionnaire 
Food Crude OR (95% CI) aOR1 (95% CI) Crude OR (95% CI) aOR1 (95% CI) 
 Frequency of intake2 Frequency of intake2 Frequency of intake2 Frequency of intake2 
 1-2/week 3+/week 1-2/week 3+/week 1-2/week 3+/week 1-2/week 3+/week 
Meat  1.16 (0.8-1.8) 1.08 (0.7-1.7) 1.19 (0.8-1.8) 1.11 (0.7-1.8) 0.73 (0.4-1.4) 1.00 (0.5-1.9) 0.76 (0.4-1.4) 1.00 (0.5-2.0) 
Fish 0.97 (0.7-1.3) 1.28 (0.8-1.9) 0.98 (0.7-1.3) 1.37 (0.9-2.1) 0.94 (0.6-1.4) 0.76 (0.4-1.6) 0.94 (0.6-1.4) 0.75 (0.4-1.6) 
Fruit  0.63 (0.4-1.0) 0.76 (0.5-1.2) 0.71 (0.4-1.2) 0.84 (0.5-1.4) 0.55 (0.3-1.1) 0.54 (0.3-1.0) 0.55 (0.3-1.1) 0.53 (0.3-1.0) 
Vegetables 0.98 (0.6-1.5) 0.83 (0.5-1.3) 1.01 (0.6-1.6) 0.85 (0.5-1.3) 0.91 (0.4-1.8) 0.76 (0.5-1.7) 0.90 (0.4-1.9) 0.94 (0.5-1.9) 
Pulses 1.10 (0.8-1.5) 1.27 (0.9-1.8) 1.08 (0.8-1.5) 1.22 (0.9-1.7) 0.99 (0.6-1.5) 0.83 (0.5-1.5) 1.01 (0.6-1.6) 0.91 (0.5-1.6) 
Cereal 0.74 (0.5-1.1) 0.85 (0.6-1.2) 0.76 (0.5-1.2) 0.87 (0.6-1.3) 0.66 (0.3-1.3) 0.84 (0.5-1.5) 0.69 (0.4-1.4) 0.86 (0.5-1.5) 
Pasta 0.98 (0.7-1.4) 1.14 (0.8-1.7) 1.01 (0.7-1.6) 1.18 (0.8-1.7) 0.49 (0.3-0.9) 0.77 (0.5-1.3) 0.51 (0.3-0.9) 0.85 (0.5-1.5) 
Rice 0.86 (0.5-1.5) 0.99(0.6-1.6) 0.94 (0.5-1.6) 1.07 (0.3-1.8) 0.56 (0.3-1.1) 0.66 (0.3-1.3) 0.58 (0.3-1.2) 0.73 (0.4-1.5) 
Butter  0.95  (0.7-1.2) 0.80 (0.5-1.2) 0.93 (0.7-1.2) 0.83 (0.6-1.2) 0.80 (0.5-1.2) 0.70 (0.4-1.3) 0.81 (0.5-1.3) 0.68 (0.4-1.3) 
Margarine 1.05 (0.8-1.4) 1.48 (1.0-2.1) 1.07 (0.8-1.5) 1.45 (1.0-2.1) 0.85 (0.5-1.3) 0.52 (0.2-1.1) 0.83 (0.5-1.3) 0.52 (0.2-1.1) 
Nuts 1.16 (0.9-1.6) 1.59 (1.1-2.3) 1.12 (0.8-1.5) 1.58 (1.1-2.2) 0.94 (0.6-1.5) 0.91 (0.5-1.6) 0.99 (0.6-1.6) 1.00 (0.6-1.7) 
Potatoes 0.84 (0.5-1.5) 0.91 (0.5-1.5) 0.94 (0.5-1.7) 1.00 (0.6-2.1) 1.29 (0.6-3.0) 0.78 (0.3-1.7) 1.45 (0.6-3.6) 0.91 (0.4-2.2) 
Milk  0.79 (0.5-1.2) 0.92 (0.6-1.4) 0.82 (0.5-1.2) 0.96 (0.6-1.4) 0.96 (0.5-1.7) 0.78 (0.4-1.4) 1.11 (0.6-2.1) 0.83 (0.4-1.6) 
Eggs 0.90 (0.6-1.4) 1.14 (0.7-1.8) 1.97 (0.6-1.5) 1.16 (0.7-1.8) 0.74 (0.4-1.3) 0.73 (0.4-1.4) 0.78 (0.4-1.4) 0.82 (0.4-1.6) 
Corn 1.19 (0.9-1.6) 1.60 (1.1-2.3) 1.18 (0.9-1.6) 1.50 (1.0-2.2) 0.85 (0.5-1.3) 0.95 (0.6-1.6) 0.91 (0.6-1.5) 1.10 (0.6-1.9) 
Fast food 1.00 (0.7-1.4) 1.35 (1.0-1.9) 1.07 (0.8-1.5) 1.40 (1.0-2.0) 0.78 (0.5-1.3) 1.01 (0.6-1.7) 0.79 (0.5-1.3) 1.03 (0.6-1.7) 




4.3.2) MD SCORE AND ASTHMA SYMPTOMS 
 
Overall the lowest quartile of the MD score seemed to be at highest risk for asthma 
symptoms. This association was stronger in the VQ (adjusted OR; 95%CI: second quartile 
0.6; 0.3-0.9, third quartile 0.7; 0.4-1.2, fourth quartile 0.6; 0.3-1.0) than in the WQ (second 
quartile 0.99; 0.7-1.4, third quartile 0.7; 0.5-1.1, fourth quartile 0.8; 0.6-1.2) (Table 4.8).  
 
Table 4.8 Association between different risk factors under study and current asthma 
symptoms during the past 12 months (unadjusted and adjusted Odds Ratios with 95% 
Confidence Intervals) (N=1655) 
  Current asthma symptoms Written questionnaire 
Current asthma symptoms 
Video questionnaire 
 Variables  
Crude OR 
(95%CI) a OR




Female 1 1 1 1 




≤ 10 years 1 1 1 1 
11 years 1.20 (0.9-1.6) 1.14 (0.9-1.5) 0.56 (0.4-0.9) 0.62 (0.4-1.0) 
≥ 12 years 0.96 (0.6-1.4) 0.86 (0.6-1.3) 0.76 (0.4-1.4) 0.86 (0.5-1.6) 
Place of living 
Rural  1 1 1 1 
Urban 0.68 (0.5-0.9) 0.69 (0.5-0.9) 2.32 (1.3-4.1) 2.24 (1.3-4.0) 
Body mass index  
Normal weight 1 - 1 - 
Overweight 0.95 (0.7-1.3) - 0.95 (0.6-1.5) - 
Obesity 1.12 (0.7-1.8) - 1.45 (0.7-2.8) - 
Intense exercise  
  
  
Never/ Occasionally 1 - 1 - 
1-2 times per week 0.90 (0.6-1.3) - 0.68 (0.4-1.1) - 




≤ 2 hours per week 1 - 1 - 
>3 hours per week 1.05 (0.8-1.4) - 1.07 (0.7-1.6) - 
Time playing video 
games  
  
≤ 2 hours per day 1 - 1 - 
>3 hours per day 1.41 (0.9-2.0) - 1.40 (0.8-2.5) - 
Mediterranean 
diet score 
Quartile 1 1 1 1 1 
Quartile 2 0.98 (0.7-1.4) 0.99 (0.7-1.4) 0.57 (0.3-1.0) 0.56 (0.3-0.9) 
Quartile 3 0.71 (0.5-1.0) 0.72 (0.5-1.1) 0.73 (0.4-1.3) 0.70 (0.4-1.2) 
Quartile 4 0.84 (0.6-1.2) 0.84 (0.6-1.2) 0.63 (0.4-1.1) 0.59 (0.3-1.0) 







This is the first study in Bolivia exploring the prevalence and risk factors of asthma and 
allergies in a representative sample of children from urban and rural areas using standardized 
methods. 
Our results showed a similar pattern of asthma and allergies diseases as reported in Latin 
America. It seems that modifiable environmental factors such as diet, outdoor or indoor 
environmental factors and hygiene conditions at home were associated with an increased risk 
of asthma and allergies in children living in this region.  
Next we are going to discuss different aspects related with methods and results of our study.  
5.1) METHODS 
 
5.1.1) DESIGN  
 
A limitation of our study is related to the cross-sectional design, with the exposure and 
outcome being measured simultaneously, thus it is not possible to determine the temporality 
of the association and then causality. Although this design is prone to induce recall bias, we 
assume that blinding the participants to the hypothesis under investigation minimized this 
concern. 
 
5.1.2) STUDY POPULATION  
 
The participation was similar to the one reported from other studies following the ISAAC 
protocol in Latin America78. Although the participation was over 90%, 7 out of the selected 
43 schools did not agree to participate (16%). Most of these schools were from urban areas. 
The main reason for non-participation was the frequent implementation of different 
governmental programs, which interrupt the education schedule. It is not assumed that this 
might have resulted in selection bias.  
Our study population differed from the one suggested by the International Study of Asthma 
and Allergies in Childhood 56. We included children in the 5th grade (age range 9-15 years) as 




Bolivia drop-out rate in following grades is high especially in public schools149. We 
considered that these children are able to understand and adequately respond the 
questionnaire. The alternative to select 1st grade pupils and use the International Study of 
Asthma and Allergies in Childhood parental questionnaire was omitted due the overall adults 




Given the sociocultural and educational background differences in our study population, we 
considered necessary to include the video questionnaire to explore prevalence of asthma 
symptoms and its association with diet and environmental risk factors as it has been described 
as being sensitive to language, culture, or literacy differences154, 162. 
 
Although the written questionnaire has been proven to be valid for eczema and rhinitis 
symptoms163, 164 it is possible that the results were also affected by interpretation problems 
related to cultural and educational background differences especially in rural areas. However, 
the prevalence of rhinitis and eczema symptoms was comparable to previous Latin American 
studies77.  
 
In our analysis to explore risk factors, we used a symptom based definition of asthma, 
rhinoconjunctivitis and eczema in order to avoid major diagnostic differences related to 
access to medical care, language and medical practice. We preferred to use the 12-months 
prevalence of symptoms over lifetime prevalence as previous studies have shown that this 
definition is less prone to recall bias165.  
 
The ISAAC environmental questionnaire was chosen to explore diet and environmental 
factors, since it is a standardized instrument which has been used successfully in different 
contexts166. Nevertheless, this instrument has certain limitations to explore diet: it only 
assesses current information on food consumption; it does not assess the amount, combination 






5.1.4) FIELD WORK 
 
Field work of our study included several recommendations by the ISAAC project. These 
recommendations are related to the approach to schools, parents and children (e.g. avoid 
mentioning the terms "asthma," "rhinitis" and “”eczema” at any stage of the field work), 
information management (e.g. double data entry, no change questionnaire responses)56. 
Adherence to ISAAC methodology and field work, allowed us to perform the comparison of 
our results with similar ones in a reliable way including international reports. 
5.1.5) STATISTICAL ANALYSIS 
  
Although cross sectional design is appropriate mainly for descriptive research, it is also used 
in some etiological studies, considering its limitation to establish causality. Two ratio 
measures of effect are suggested for analysis of cross sectional data with a dichotomous 
outcome variable: the prevalence odds ratio (POR) and the prevalence ratio (PRR). The 
choice between these two has been the source of ongoing debate in the epidemiological 
literature over the past few years168. Although PRR appears to be a more meaningful statistic 
for cross sectional data, epidemiological studies reported more frequently POR than PRR, 
possible due to the routine use of logistic regression. But several studies have showed that if 
the condition under study (outcome) is of low prevalence, then POR would be numerically 
similar to PRR169.  
In our study POR were calculated due to the widespread use of this measure in International 
Studies on this topic and therefore the increased possibility to compare our results. Moreover, 
given that we analyzed chronic diseases, we could assume that both measures (PRR and POR) 
may not be very different. 
 
One of the statistical challenges when computing scores such as Mediterranean diet score is 
related to dealing with missing data. Although have been reported that multiple imputation 
method is a good alternative to manage missing data170, 171, not many studies have used this 
method to calculate the Mediterranean diet score and then the association with diet and 






5.2) RESULTS  
 
5.2.1) PREVALENCE OF SYMPTOMS  
 
The prevalence of asthma, rhinoconjunctivitis and eczema symptoms found in this study was 
within the range reported for South America77, 78, 130. Difference between rural and urban areas 
indicated higher prevalences for urban areas, although this difference was not significant and 
it was smaller in comparison with previous studies85. 
In accordance with previous studies, we have found a low agreement between written and 
video questionnaire for asthma with much higher prevalence in the written than in the video 
questionnaire154.  Given the extremely high prevalence in the written asthma questionnaire as 
compared to the video questionnaire and to other studies in Latin America133 one might 
assume that the results reported by video questionnaire could be more reliable than those from 
written questionnaire. Overall, the prevalence of current asthma symptoms (6.4%) were lower 
than the Latin American average (10.3%), especially those reported from the neighboring 
countries (17.1% in Peru, 12.1% in Chile, 10.4% in Paraguay and 8.1% in Argentina)133. It is 
likely that in our study, the unfamiliarity with the terms used in the written questionnaire 
could cause over reporting of symptoms especially in the rural population172. 
Current and severe rhinoconjunctivitis prevalence were higher than those reported in Latin 
America (17.3% and 1.1% respectively), but are quite similar with prevalence in urban areas 
in Santa Cruz, Bolivia (22.4% and 1.8% respectively) 77. In addition, atopic eczema 
prevalence is similar than the average prevalence value for Latin America (9.5%) 130.  
 
Several studies explored the possible relation between ethnicity, poverty, environmental 
pollution, level of industrialization, health conditions or genetic factors and the prevalence of 
asthma and allergies symptoms. The real impact of such factors remains unclear since large 
differences have been described specially in Latin America109, but there is common agreement 
about the importance of environmental factors for the development of asthma and allergic 
diseases173. Although no significant differences were found in current symptoms of asthma, 
rhinoconjunctivitis and eczema between urban and rural areas,  our study found a lower 




poverty is above 70%, with more than 40% of the population engaged in agricultural activities 
and more than 90% of the population identifying themselves with native Quechua ethnicity147.  
 
5.2.2) ASSOCIATION BETWEEN ENVIRONMENTAL FACTORS AND ASTHMA, 
RHINOCONJUNCTIVITIS AND ECZEMA SYMPTOMS 
 
In this analysis, outdoor as well as indoor environmental factors and hygiene conditions at 
home were associated with an increased risk of asthma and allergies in children living in 
Oropeza province in Bolivia. This contributes to our understanding of the importance of 
modifiable environmental factors in the development of asthma and allergies in children in 
Bolivia.  
 
Some studies have stressed the importance of early exposure (first year of life) of some 
environmental factors on the development of asthma and allergies174, 175. In our study it was 
not possible to reliably explore this information. One might assume that most of these 
exposures have not changed over time especially in the Bolivian setting. Therefore, in our 
study current exposure might well reflect early life exposure.  
 
The ISAAC video questionnaire was described as a sensitive tool for language, culture, or 
literacy differences to assess asthma symptoms154, 162. As our study population presents a large 
range of sociocultural and educational background we implemented both – the video as well 
as the written questionnaire. The consistency of our results indicates the validity of the 
findings. 
The results of this study have pointed out several sources of indoor and outdoor air pollution 
as risk factors of asthma and allergies in children. It is well known that environmental tobacco 
smoke is associated with asthma symptoms. A recent systematic review and meta-analysis of 
79 prospective studies found that exposure to pre- or postnatal environmental tobacco smoke 
exposure was associated with a 30% to 70% increased risk of incident wheezing165, 176. 
Although the evidence is not too strong for rhinoconjunctivitis and eczema symptoms177, our 
results support this association.  
Even though the associations between outdoor air pollution with asthma and allergy 




reported by the International Study of Asthma and Allergies in Childhood  phase 3 showing a 
positive association between intense truck traffic and asthma, rhinoconjuntivitis and eczema 
symptoms178. It could be explained by the interaction of air pollutants with the immune 
system, increasing the allergenicity of these pathologies. 
 
Our results support previous findings reported for Latin America86, 93, 109, showing that asthma 
and allergies are associated with poverty and inequality. Poverty is a complex social and 
economic condition and it is not easy to identify the effects of the many associated 
environmental and lifestyle factors contributing on the development of asthma and allergies86, 
93. Poverty is associated with a number of known risk factors for asthma at individual and 
neighbourhood level as smoking113, 177, high indoor and outdoor pollution179-182, diet166, 183, 
ethnicity184-186, lack of good quality potable water187, sewer systems188, and waste collection 
and disposal189.  
In the same way poverty is linked with poor hygienic conditions. This might explain why our 
as well as other Latin American studies73, 86, 109 have shown lack of hygiene as risk factor for 
asthma and allergies while other – mainly European studies190-192 – have indicated an inverse 
relationship between low level of hygiene and such diseases. Our findings are consistent for 
asthma, allergic rhinoconjuntivitis and - to some extend – eczema. This indicates that 
differences in phenotype of asthma, as discussed in earlier studies93, 193, are not the main 
reason for the contradicting findings between Europe and Latin America.  
 
5.2.3) DIET AND ASTHMA SYMPTOMS 
 
The respective analysis suggests that Mediterranean diet may be a protective factor for current 
asthma symptoms in school-age children from a culturally diverse, mainly rural region of 
Bolivia. In contrast, results for single food groups were weak and inconsistent.  
 
Two approaches were used to assess diet: individual food groups and the Mediterranean diet 
score, the latter has been suggested as a good approach in epidemiological studies120, 194 and a 
good alternative to explore diet food behavior in different contexts improving statistical 
power122.  
 
The video scene chosen to define asthmas symptoms might reflect more severe asthma than 




This, as well as the difference in the validity of both instruments in the population under study 
might explain why the association between Mediterranean diet and asthma symptoms was 
stronger for the video questionnaire than for the written questionnaire.  
In agreement with other studies, our results showed an association between fast food 
consumption166 and corn consumption and asthma symptoms, these association were only 
statistically significant  in the written questionnaire. Some of the fast food components have 
been linked with modulation of immune reactions and consequently asthma117, 196. Although 
there are no studies addressing the corn influence on asthma symptoms, such relationship 
needs to be assessed in the region considering corn consumption as a marker of different style 
of diet in the region. 
Although not statistically significant in the multivariate models, our results support the other 
studies findings showing a protective effect of fruit, vegetables, cereal, rice, butter and milk 
consumption on current asthma symptoms121, 161, 166.  
Margarine, nuts and pasta showed inconsistences between written questionnaire and video 
questionnaire, such results might be explained as a chance finding; nevertheless, it is possible 
that children did not identify properly margarine and butter, being margarine the food with the 
highest number of missing values (11%). In addition, nuts have been suggested as protective 
factor for asthma symptoms in previous studies197, but our study showed nuts as a risk factor. 
One might assume the consumption of salty nuts snacks competes with the consumption of 
fruits and other healthy snacks and salty snacks have shown a positive association with 
asthma symptoms198.  
Our results assessing dietary patterns support the hypothesis that the effect of food on asthma 
symptoms is achieved by the interaction or mixture of several components in the diet117, 121, 
122.  
Some studies have proposed that the Mediterranean diet could explain its inverse association 
with asthma symptoms through some mechanisms proposed previously. First, this diet is 
characterized by high consumption of foods rich in antioxidants which improve host 
resistence117, 199, and second, a higher consumption of ω-3 PUFAs in comparison with  ω-6, 
which decrease susceptibility to allergies by inhibiting synthesis of prostaglandin E2 (PGE2) 
and promoting the  differentiation into helper-inducer T-lymphocytes (Th1) cells, and 
suppressing the Th2-cell phenotype by decreasing class switching to IgE117.  
Our populations showed to have a medium adherence to Mediterranean diet compared to 
other population in Spain200 and a particular low consumption of one of the main components 




low availability and high cost of fish in Bolivia result in a high consumption of beef, chicken 
and pork. Additionally, the regional food cooking process is characterized by high salt 
content, condiments and fried food, not corresponding to the traditional cooking process of 







This is the first report of childhood asthma and allergy symptoms in rural and urban areas of 
Bolivia using a standardized methodology. The prevalence for asthma, rhinoconjunctivitis and 
eczema symptoms was within the range reported for South America. It shows that asthma and 
allergies are an important public health problem in Latin America, and also in this region of 
Bolivia.  
The overall results of prevalence showed that children living in urban areas of Bolivia seem to 
have a higher prevalence only in severe symptoms of asthma and allergies compared to 
children living in the country side.  
The results regarding association between environmental factors and asthma and allergies 
support previous findings reported for Latin America, showing that asthma and allergies are 
associated with poverty. Therefore health policies that promote the reduction of harmful 
environmental factors such as environmental tobacco smoke or precarious housing conditions 
are needed in order to reduce the important disease burden of these pathologies.  
Our results on the relationship of diet and asthma suggest a protective association between 
Mediterranean diet and current asthma symptoms. For individual foods the results are 
inconsistent and less clear, suggesting the importance of the interaction of several components 
in the diet. However, there is not enough evidence to suggest Mediterranean diet as public 
health police.  Our results suggest the need of promotion of healthy dietary habits among 
children in order to avoid the rapid increase of non-communicable diseases in this region. 
 
The implementation of prospective and multidisciplinary studies in this region comparing 
high and low risk populations could offer an advantage since Bolivia and other Latin 
American countries are currently coursing an epidemiological transition process, with recent 
lifestyle changes and cultural diverse backgrounds, which could be better addressed in the 
long term. Performing such studies, may provide important clues to identify potential 
protective factors and avoidable risk factors that could be used to design new interventions. 
 
More research is needed to identify causes of asthma and allergies, considering phenotype, 




the complex mechanism for the development of asthma and allergies in children and support 
the need for public health measures according the local context.  
 
Bolivia offers important research opportunities to deepen in this topic because the enormous 
diversity in social, environmental, genetic factors and current step of epidemiological 
transition. It could help to understand the large differences in prevalence of asthma and 
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10.1) INFORMATION LETTER FOR SCHOOL (IN SPANISH) 
Sucre,  ……………. de 2011 
Sr (a). 
Director (a) de Unidad Educativa  …………………… 
Ref: Participación en encuesta sobre problemas de salud en niños 
Estimado (a) Director (a): 
A tiempo de saludarle y desearle éxito en sus funciones, me permito comunicarle que la Universidad Alemana 
Ludwig Maximilian Universitet junto a mi persona estamos llevando adelante un estudio con el objetivo de 
conocer la situación de algunos problemas en la función respiratoria, en la nariz y en la piel de niños de edad 
escolar. La información obtenida en este estudio podrá guiar la implementación de programas de salud de 
manera adecuada a la realidad del departamento. 
Por tal motivo estamos solicitando la participación de los niños de quinto año de enseñanza básica, previa 
autorización de los padres,  en varias escuelas del departamento de Chuquisaca seleccionadas al azar, y dentro de 
las cuales se encuentra su establecimiento educativo. 
Para la realización de la investigación solicitamos gentilmente la colaboración de su escuela en las siguientes 
actividades: 
1. Durante el período de coordinación, un miembro del equipo de investigación traerá a su escuela hojas de 
información para los padres, para que sean distribuidas una semana antes del estudio. 
2. El día de la visita a la escuela, le pediremos a los niños que completen dos cuestionarios escritos, también se 
les mostrará un video de 10 minutos sobre ejercicio y respiración y finalmente se les medirá el peso y talla. 
En total necesitaremos alrededor de 2 horas de clases para terminar todas las actividades. 
3.- Al finalizar el proyecto, el investigador se compromete hacer llegar a su establecimiento los resultados 
generales de la investigación haciendo énfasis en su establecimiento, pero sin identificar a ningún niño en 
particular. 
 
Consideramos pertinente informarle que este estudio ha sido evaluado y aprobado por la Comisión Nacional de 
Ética en la investigación y es de conocimiento del Servicio Departamental de Educación de Chuquisaca. Todo 
esto se ha realizado en procura de brindarle la mayor seguridad y confianza para que los niños participen en el 
estudio. 
 
Si usted necesita mayor información, puede ponerse en contacto con la persona responsable a los teléfonos que 
figuran abajo. 
Agradeciendo de antemano su colaboración, se despide atentamente, 
 
Dra. María Teresa Solís Soto 
Investigador Responsable 
Fono: 64- 35869 - Celular: 734 63935 
e-mail: maritesolissoto@yahoo.es  




10.2) WRITTEN QUESTIONNAIRE (IN SPANISH) 
 
ENCUESTA SOBRE PROBLEMAS DE SALUD EN LA NARIZ, PIEL Y RESPIRACIÓN  
 
 
Por favor escribe tus respuestas en el espacio proporcionado para cada una de ellas. Esta información será 
estrictamente confidencial (nadie mencionará tu nombre). 
 
Nombre y apellido: …………………………………………...……………………………………. 
 
Escuela/Colegio: …………………………..…  Curso: …………       Fecha de hoy:    ____/____/_____ 
                          Día   Mes   Año 
¿Qué edad tienes?: ............ años                 ¿En qué fecha naciste?:____/_______/_____      
          Día     Mes      Año   
 
Sexo: 
                          
1. ¿Alguna vez en tu vida tuviste silbido al pecho? 
 
         SI CONTESTASTE “NO”  SALTATE A LA PREGUNTA  
 
2. ¿Has tenido silbido al pecho en estos últimos 12 meses (último año)? 
       SI      NO  
 
3. ¿Cuántos ataques o crisis de silbido al pecho has tenido en estos últimos 12 meses (último año)? 
              NINGUNO       1 a 3          4 a 12                   Más de 12 
 
4. ¿En estos últimos 12 meses (último año) cuántas veces te has despertado en la noche debido a silbido al 
pecho? 
Nunca he despertado con silbido al pecho       
Menos de una noche por semana                    
Una o más noches por semana                       
 
5. ¿En estos últimos 12 meses (último año) has tenido silbido al pecho tan fuerte como para no dejarte hablar 
más de una o dos palabras entre cada respiración? 
SI       NO  
 
  





6.  ¿Has tenido asma alguna vez en tu vida? 
 
SI       NO  
 
7. ¿En estos últimos 12 meses (último año) has tenido silbido al pecho durante o después de hacer  ejercicios 
(correr, etc.)? 
SI       NO  
 
8. ¿En estos últimos 12 meses (último año) has tenido tos seca en la noche? (Cuando NO estabas resfriado ni con 
infecciones respiratorias). 






Todas las preguntas a continuación se refieren a problemas de la nariz que ocurren cuando NO ESTAS CON 
GRIPE NI CON RESFRIO. 
 
9. ¿Alguna vez en tu vida has tenido problemas de estornudos, de que te corra (moco), o se te tape la nariz? 
(cuando NO TENÍAS RESFRÍO COMÚN NI GRIPE). 
 
SI CONTESTASTE “NO” SALTATE  A LA PREGUNTA  
 
10. ¿En los últimos 12 meses tuviste problemas de estornudos, de que te corriera (moco), o se te tapara la nariz? 




11. En los últimos 12 meses junto con el problema de la nariz ¿te picaban y lloraban los ojos? 
 
 
12. ¿En qué meses del año ocurrían estos problemas en la nariz? (MARCA TODAS LAS OPCIONES QUE 
SEAN NECESARIAS) 
 
Enero   Febrero   Marzo   Abril  
Mayo   Junio    Julio   Agosto  
Septiembre   Octubre   Noviembre   Diciembre  
 
13. ¿En los últimos 12 meses en qué cantidad interfirieron estos problemas de tu nariz con tus actividades 
diarias? 
 








SI       NO  
SI       NO  
SI       NO  






15. ¿Has tenido alguna vez en la vida granos o ronchas acompañado de picazón que estén yéndose y volviendo 
durante por lo menos 6 meses? 
 
        SI CONTESTASTE “NO” SALTATE A LA PREGUNTA  
 
 




17. ¿Los granos o ronchas con picazón te han salido en alguno de los siguientes lugares del cuerpo?  (MARCA 
TODAS LAS OPCIONES QUE SEAN NECESARIAS) 
 
Pliegues de los codos    Detrás de las rodillas    Alrededor de los ojos  
Cuello     Tobillos     Orejas  
Nalgas    Otro lugar      
 
18. ¿Has estado completamente sano de este problema de la piel (granos o ronchas con picazón) en algún 




19. ¿Cuántas veces en estos últimos 12 meses (en promedio) te has mantenido despierto en la noche debido a 
ésta picazón con granos o ronchas? 
 
Ninguna  vez en los últimos 12 meses  
Menos de una noche por semana        
Una o más noches por semana             
 
 




SI       NO  
SI       NO  
SI       NO  






21.- En los pasados 12 meses, en promedio,  ¿qué tan frecuentemente comiste o bebiste los  siguientes 
alimentos? (MARQUE UNA OPCIÓN PARA CADA ALIMENTO) 
                                    Ocasionalmente    Una o dos veces    Tres o más veces 
                                   o nunca              a la semana       a la semana 
 
 
Carne (res, cerdo, pollo, cordero)    
   
 
Pescados    
   
 
Fruta (cualquier tipo)    
   
 
Vegetales frescos (lechugas, tomates, etc.)    
   
 
Porotos, lentejas, garbanzos, otros    
   
 
Cereal (incluyendo pan)    
   
 
Pasta (fideos, coditos, tallarines, etc.)    
   
 
Arroz    
   
 
Mantequilla    
   
 
Margarina    
   
Nueces, maní    
   
 
Papas    
   
 
Leche    
   
 
Huevo    
   
 
Maiz    
   
 
Hamburguesas, Hot Dogs, Pollo frito (u 
otras  “comidas rápidas”) 
   




22.- ¿Cuántas veces a la semana realizas EJERCICIO FÍSICO lo suficientemente intenso como para agitar tu 
respiración?  
Ocasionalmente o nunca 
 
 
Una o dos veces a la semana 
 
 




23.- Durante una semana normal, ¿cuántas horas al día VES TELEVISIÓN?  
NO veo Televisión 
 
 
Menos de una hora 
 
 
De una a dos horas 
 
 
De tres a cuatro horas 
 
 




24.- Durante una semana normal, ¿cuántas horas al día JUEGAS TILINES O ALGÚN VIDEOJUEGO?  
NO juego Tilines ni videojuegos 
 
 
Menos de una hora 
 
 
De una a dos horas 
 
 
De tres a cuatro horas 
 
 




25.-  ¿Cuántos hermanos y hermanas MAYORES tienes? 
 N° de hermanos y hermanas MAYORES (en total):………..     No tengo hermanos(as) MAYORES 
 
26.-  ¿Cuántos hermanos y hermanas MENORES tienes? 
 
    N° de hermanos y hermanas MENORES (en total):………..      No tengo hermanos(as) MENORES 
         
27.- ¿Has tenido algún GATO en tu casa en los últimos 12 meses (último año)? 
 
 




SI       NO  




29.- ¿Has tenido contacto regular (por lo menos una vez por semana) con ANIMALES DE GRANJA (vacas, 
cabras, ovejas, cerdos, gallinas, pollos o pavos) en los últimos 12 meses? 
   
 
30.- ¿Fuma cigarrillos tu MAMÁ o la persona que te cuida? 
 
 
31.- ¿Fuma cigarrillos tu PAPÁ o la persona que te cuida? 
 
 
32.- ¿TÚ has fumado alguna vez cigarrillos? 
 
 
33.- ¿Cuántas personas de las que habitan en tu casa (incluyendo tus papás) FUMAN CIGARRILLOS? 
Número de personas:…….......     Ninguna Fuma  
 
34.- ¿Durante cuántos años has vivido en este lugar (en esta ciudad o comunidad)? 
Número de años:…………..      No recuerdo 
 
35.- ¿Dónde viviste en tu primer año de vida (cuando tenías 1 año de edad)? 
Nombre del lugar (Ciudad o comunidad): ……………………………. No recuerdo  
 







Frecuentemente durante el día 
 
 









SI       NO  
SI       NO  
SI       NO  
SI       NO  
  
 
Gas (garrafas o 
tubería) 




38.- ¿Qué tipo de combustible se utiliza habitualmente para calentar tu casa? (MARCA LA OPCIÓN MÁS 
IMPORTANTE) 
 
39.- ¿Que bichos existen en tu casa? 
 









NINGUNO  Gas (calentador 
de gas) 





 Otro  
   
 
  
Pulgas  Garrapatas  Vinchucas  Chinches  Ratones  Moscas  
   
 
Ladrillo, cemento u 
hormigón 
 Madera  Adobe    










41.- ¿Cuál es el material más importante del piso de tu casa? (UNA SOLA OPCIÓN) 
 
42.- ¿De dónde obtienen el AGUA PARA BEBER O COCINAR en tu casa? 
 
43.- ¿Cómo es el BAÑO de tu casa? 
44.- ¿Tienen un CUARTO EXCLUSIVO PARA COCINAR  (la cocina está en un cuarto separado)? 
SI       NO  
 
  
    




















Pileta dentro de tu 
casa 
 Pileta pública  Río, vertiente, lago 
o laguna 
 Pozo con Bomba  
        
 
  
Pozo sin bomba  Carro repartidor  Otro lugar    
 
 
   






45.- ¿Cuántas personas viven en tu casa (incluyéndote)? 
 Número de personas:…………………….  
 
46.- ¿Cuantos cuartos o habitaciones se ocupan para dormir? 
 Número de cuartos:…………………….  
 
47.- En tu casa tienen: (Marca TODAS las opciones que correspondan) 
  
Radio o equipo de 
sonido 










10.3) ISAAC INTERNATIONAL VIDEO QUESTIONNAIRE ANSWER SHEET (IN 
SPANISH) 
 
Nombre y apellido: ………………………………………………….    
Curso:………………………… 
    
ESCENA 
1 
La primera escena es de un joven descansando. 
      ¿Tu respiración ha sido así, en algún momento de tu vida?            SI                            NO 
 
Si contestas SI:    
¿Ha pasado esto en el último año?                                         SI                    NO 
 
Si contestas SI:    
¿Ha pasado esto una o más veces  en un mes?            SI                   NO 
  
 
    
ESCENA 
2 
La segunda escena es de dos jóvenes haciendo ejercicio. Uno de ellos tiene una camisa oscura, y la 
otra persona tiene una camisa blanca. 
 
      ¿Alguna vez tu respiración ha sido como la del niño con camisa oscura durante o después del 
ejercicio?                                                                                                 SI                    NO      
Si contestas SI:    
¿Ha pasado esto en el último año?                                         SI                       NO 
 
Si contestas SI:    




    
ESCENA 
3 
La tercera escena es de un joven que despierta en la noche. 
 
      ¿Alguna vez en tu vida tú has despertado de esa manera?           SI                          NO 
                     
Si contestas SI:    
¿Ha pasado esto en el último año?                                          SI                        NO 
 
Si contestas SI:    











    
ESCENA 
5 
La escena final es de otra persona en reposo. 
      ¿Tu respiración ha sido así, en algún momento de tu vida?             SI                         NO 
                     
Si contestas SI:    
¿Ha pasado esto en el último año?                                            SI                      NO 
 
Si contestas SI:    







    
ESCENA 
4 
La cuarta escena también es de un joven despierto  por la noche. 
      ¿Alguna vez en tu vida tú has despertado de esa manera?         SI                            NO 
                     
Si contestas SI:    
¿Ha pasado esto en el último año?                                           SI                       NO 
 
Si contestas SI:    





10.4) EHICS APPROVAL GIVEN BY THE NATIONAL RESEARCH ETHICS 





10.5) EHICS APPROVAL GIVEN BY THE NATIONAL RESEARCH ETHICS 











10.6) CONSENT FORM FOR PARENTS (IN SPANISH) 
Sucre, ……………….. de 2011 
Estimado padre de familia: 
 
 
Ref: Invitación para participar en encuesta sobre problemas de salud en niños 
 
Mi nombre es María Teresa, estudiante de doctorado en la universidad alemana Ludwig Maximilians.  Me 
permito comunicarle estamos llevando adelante un estudio con el objetivo de conocer la situación de algunos 
problemas en la función respiratoria, en la nariz y en la piel de niños(as)  de quinto año de enseñanza básica de 
Chuquisaca, previa autorización de sus padres. La información obtenida podrá guiar la implementación de 
programas de salud de manera adecuada a la realidad del departamento. 
Durante una visita programada al establecimiento educativo se pedirá a los niños(as) que llenen un cuestionario 
sobre salud y algunos factores de riesgo, posteriormente se les mostrará a los niños(as) un video de 5 minutos 
sobre ejercicio y respiración y se les pedirá que llene otro cuestionario corto, finalmente se medirá peso y talla a 
todos los niños(as) participantes. Todas estas actividades tomarán alrededor de 2 horas del horario de clases y no 
representan ningún riesgo para la salud. 
 
Junto con extenderle la invitación para que su hijo(a) participe, le aseguramos que la información obtenida será 
tratada de forma estrictamente confidencial, sólo se trabajará con un código en la computadora y en ningún caso 
los nombres de los niños(as) serán usados para el análisis individual. 
Este estudio ha sido evaluado y aprobado por la Comisión Nacional de Éti ca en la investigación y es de 
conocimiento del Servicio Departamental de Educación de Chuquisaca, y las autoridades del Colegio de su 
hijo(a). Todo esto se ha realizado en procura de brindarle la mayor seguridad y confianza para que su hijo(a) 
participe en este estudio. 
 
 
Considerando la información anterior,  
 
Yo......………………………………………, padre del menor: ………………………………………… 
 
NO deseo que mi hijo participe 
 
  





Si desea escribir el motivo para no participar puede mencionarlo aquí (opcional): 
……………………………………………………………………………………… 
 
Cualquier decisión NO tendrá ninguna consecuencia desfavorable en la relación de usted o de su hijo con la 
escuela. 
 
Nombre de su hijo/hija:…………………………………… 
Nombre del padre/madre/tutor…………………………………… 
Firma del padre/madre/tutor …………………………………… 
Fecha ___________________________ 





Se ha programado la visita al establecimiento de su hijo(a) en fecha……de……………del presente año, por lo 
que solicitamos devolver esta hoja firmada antes del día de la visita.  
 
 
Si usted necesita mayor información, por favor no dude en comunicarse. 
 
 
Dra. María Teresa Solís Soto 
Investigador responsable 
 
Fono: 64- 35869 - Celular: 734 63935 
e-mail: maritesolissoto@yahoo.es 





10.7) CONSENT FORM FOR PARENTS (IN ENGLISH) 
Sucre, ……………….. 2011 
I am María Teresa Solís Soto, a PhD Student at Ludwig Maximilians University in Germany.  I am doing some 
research in order to know the prevalence and risk factors of some respiratory, nose and skin problems in children 
in the fifth elementary grade of Chuquisaca. The information obtained will guide the implementation of health 
programs according the needs of the region.  
In our research we will talk to many children, both girls and boys, and ask them a number of questions. 
Whenever researchers study children, we talk to the parents and ask them for their permission. If you agree, then 
the next thing I will do is ask your daughter/son for their agreement as well. Both of you have to agree 
independently before I can begin. 
During a visit scheduled to the school, your daughter/son will fill out a health questionnaire, then your children 
will see a video questionnaire of seven minutes about exercise and breathing and asked to complete another short 
questionnaire, finally we will measure the weight and height for all children participants. All these activities will 
take about 2 hours of class. 
The information recorded is confidential, and no one else except the principal investigator will have access to 
their questionnaire, and in any case the names of the children will be used for individual analysis. 
At the end of the study, a written report will be given to the school which they can share with their families.  
You may choose not to have your child participate in this study and your child does not have to take part in this 
research if she/he does not wish to do so. Choosing to participate or not will not affect either your own or your 
child's future treatment at the school in any way.  
This proposal has been reviewed and approved by National Commission on Ethics in Research (CEI – San 
Andrés University), which is a committee whose task it is to make sure that research participants are protected 
from harm. 
I have read the foregoing information, and: 
Name of your daughter/son:…………………………………… 
Name of Parent/Mather/Tutor…………………………………… 
Signature of Parent/Mather/Tutor…………………………………… 
Date ___________________________ 
 Day/month/year    
We have scheduled the visit to the educational establishment of your child on (day/month/year), so we ask you 
to return this signed form before the day of the visit. 
If you need more information, please feel free to contact. 
Maria Teresa Solis Soto, MD, MPH, MEP 
Principal Investigator 
Phone: 64-35869 - Cell: 734 63 935 
E-mail: maritesolissoto@yahoo.es 
17 Manuel Duran Street. Sucre, Bolivia 
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